capabilitiesOfCellInvasion,105.txt
diagnosisOfBreastCancer,113.txt
heterogeneousDisease,45.txt
13,178.txt
familyMemberAffectedWithCancer,202.txt
features,32.txt
caseOfWomanOnNeratinibForHer-2PositiveInfiltratingDuctalCarcinoma,78.txt
patients,231.txt
betterPrognosis,127.txt
UC,60.txt
survival,240.txt
understandingOfEmergingConceptsOfTumorBiology,21.txt
high,17.txt
advancedBreastCancerTreatment,104.txt
unusualCaseOfPtosis,121.txt
access,145.txt
role,44.txt
included,66.txt
typical,26.txt
pathologicEvaluation,167.txt
moreInclined,238.txt
revealed,130.txt
at25HPost-injectionGreaterInTumorBedThanInKidneyRespectively,134.txt
inConclusionDownregulatedInBreastCancer,131.txt
correlation,174.txt
associated,77.txt
performed,130.txt
age,177.txt
canDetectedWithHelpOfVariousProfilingMethods,137.txt
stageIiiBreastCaner,139.txt
tissueStorageTime,245.txt
mostCases,215.txt
especiallyPromising,50.txt
transformed,29.txt
reportOnPerformanceOfBayesClassifiersLikeTreeAugmentedNaiveBayes,40.txt
divided,162.txt
canBenign,166.txt
related,142.txt
individualRiskOfRecurrence,188.txt
Israel,64.txt
dualRoleOfL-3InBl1-subtypeTriple-negativeBreastCancer,106.txt
haveBackbone,9.txt
higherProportionOfPatientsWithLymphedema,19.txt
imagingModalities,210.txt
causal,186.txt
clinico-epidemiologicalFeaturesOfBreastCancer,39.txt
perceptionOfQualityOfCareProvidedByCancerCareNetworkForEarlyDetectionOfBreastCancer,5.txt
performedFromInceptionToJanuary312018,212.txt
insights,81.txt
used,175.txt
values,169.txt
13PercecntOfDeaths,42.txt
littleSurvivalVariance,102.txt
yetUnclear,75.txt
opportunities,3.txt
relativeThoseOfControls,244.txt
additionalIndicator,141.txt
leastAbsoluteShrinkage,194.txt
differenceBetweenDifferentBreastCancerSubtypes,192.txt
furthermoreCouldDevelopedAsPotentialTherapeuticAgentAgainstMcf7-cell-related,244.txt
assessment,109.txt
unnecessarySubsequentExaminations,50.txt
iraqiWomenWhencomparedToWesternWorld,39.txt
serious,130.txt
evidenceForbenefits,40.txt
resistant,153.txt
estrogenReceptor,67.txt
role,35.txt
inflammatoryBreastDiseaseWithUnknownEtiology,31.txt
recognized,143.txt
tackled,59.txt
shouldCo-managed,27.txt
risk,243.txt
iterativelyModified,92.txt
aspirinUse,133.txt
controlled,95.txt
rightMastectomyWithSentinelLymphNodeBiopsy,6.txt
used,63.txt
prognosisMoreAccurately,86.txt
fusionProteinsWithHaloTag,44.txt
levelExamination,50.txt
unitedStates,160.txt
possibility,229.txt
toEndDevelopedWithDrugToAntibodyRatioOf329,128.txt
queried,102.txt
CXCR4,105.txt
useful,110.txt
tumorImaging,210.txt
992PercecntOfCases,39.txt
achieved,236.txt
diagnosis,76.txt
methodologyOfInstitutoDeEvaluaciónTecnológicaEnSalud,69.txt
clinicalCharacteristicsOfCareOfBreastCancerPatients,108.txt
following,23.txt
dramaticallyIncreasedAmount,205.txt
taken,69.txt
specialEmphasisOnTheirDifferentialDiagnosis,149.txt
mir-193b-3pBinding,81.txt
associatedWithPfsAlthoughAtExtent,4.txt
heterogeneous,120.txt
effective,128.txt
involved,131.txt
factors,48.txt
variousOtherCancerInHumanBody,7.txt
prognosis,127.txt
identified,10.txt
denseBreastTissue,155.txt
thriceHigher,44.txt
metastasis,105.txt
disadvantages,79.txt
diagnosis,106.txt
oestrogenReceptorCofactors,152.txt
associated,4.txt
importanceOfNondestructiveTestingInDefectStudies,7.txt
symptom,47.txt
adjuvantAnastrozole,67.txt
preoperativeAssessment,109.txt
sleepDisturbances,228.txt
routineProcedure,124.txt
OS,86.txt
imagingFeatures,166.txt
independentPrognosticFactor,32.txt
matched,174.txt
youngerPeople,161.txt
bevelledEdges,166.txt
nudeMice,134.txt
primaryBreastCancer,153.txt
thereforeCriticalSignificance,235.txt
immunohistochemicalTechniques,74.txt
cancerDiagnosis,236.txt
years,231.txt
resistanceToAntimitoticDrugs,198.txt
prognosticFactorIndependentOfOtherClinicalVariables,190.txt
greatBenefitsAgainstBreastCancer,199.txt
established,132.txt
cause,221.txt
level,42.txt
widespreadInterest,109.txt
incidenceFactors,118.txt
21Months,4.txt
contextOfTwoCasesOfBladder,60.txt
real-worldSetting,7.txt
greater,134.txt
relationToOccurrenceOfOsteoporosisAmongVariousEthnicGroups,95.txt
willDifferentRegardingSubtypeAtDiagnosis,80.txt
detected,31.txt
included.When,19.txt
brainMetastases,73.txt
patients,17.txt
aspirin,219.txt
mostProminentCause,213.txt
192Months,72.txt
women,136.txt
required,32.txt
poor,206.txt
assessed,61.txt
pool,174.txt
worseOsThanT2aSutegory,86.txt
retrieved,20.txt
incidenceOfCardiovascularDiseaseAmong32757CancerSurvivors,179.txt
findings,31.txt
pragmaticApproachToPopulation-basedCancerScreening,53.txt
datasets,49.txt
boneDensity,26.txt
T2,97.txt
mostEffectiveTechniqueused,144.txt
macroprolactinomas,57.txt
therapy,195.txt
patientsWithMetastaticBreastCancer,242.txt
resistant,137.txt
patternsOfAssociationResults,111.txt
cross-sectionalStudies,2.txt
mainlyPostmenopausalWomen,146.txt
tumorNeoangiogenesisSimilarToBreastMagneticResonanceImaging,101.txt
breastCancerInAdultsInChildren,166.txt
tumorBurden,197.txt
children,232.txt
antibodyDrugConjugates,168.txt
retrospectivelyReviewed,72.txt
mostSensitiveTest,207.txt
coxProportionalHazardModel,103.txt
value,207.txt
noted,147.txt
limitedNumberOfCases,232.txt
her2-positiveA,4.txt
overview,207.txt
brainMetastasis,6.txt
preclinicalPhase,142.txt
breastCancer,227.txt
age,164.txt
following,151.txt
aberrantlyExpressed,131.txt
formulation,138.txt
suspected,80.txt
diagnosed,187.txt
howeverUnderutilized,138.txt
driven,152.txt
90Percecnt,191.txt
incrementalCostOfCop$251049,69.txt
monitored,162.txt
broadUseToPatients,22.txt
synthesized,181.txt
normalTissues,18.txt
outcome,62.txt
data,93.txt
VDR,95.txt
knowledgeGaps,92.txt
72Months,118.txt
thusWouldCrucialForApplicationOfPreventiveStrategies,142.txt
publicHealthChallenge,79.txt
optimalParametersInFeatureSelectionProcess,170.txt
DPV,235.txt
objectives,187.txt
applied,177.txt
cervicalCancer,115.txt
cancerCells,45.txt
65Ng/ml,48.txt
mostFrequentlyDiagnosedTumorInWomenWorldwideWithSignificantImpactOnMorbidity,219.txt
preventionOfDiagnosedBreastCancerInEstrogen-aloneArmOfWhi,21.txt
surveillancePopulation-basedData,103.txt
promoterMethylationInCertainTypesOfHumanTumors,185.txt
adenosine-inducedScEnrichment,156.txt
7PercecntForCdx2,12.txt
delay,94.txt
pax8AMetastasesOfCancer,12.txt
insights,41.txt
expression,239.txt
axillaryClearance,147.txt
nextMade,176.txt
rates,92.txt
downregulated,18.txt
genes,68.txt
determinantsOfCancer,186.txt
respectivelyFound,58.txt
mayImportantStepsDuringDiagnosis,31.txt
onlyIndicated,232.txt
breastCancerCellInvasion,82.txt
included,39.txt
method,245.txt
criticalRole,199.txt
treatments,241.txt
problem,113.txt
enlargement,73.txt
biologicallyDifferentDisease,119.txt
breastCancerControlEffortsForIdentification,40.txt
localEntropyMaximizationAlgorithm,49.txt
thereforeAdministered,197.txt
patterns,108.txt
riskFactorsForLateComplicationsAssociatedWithTivapthere,164.txt
medianFollow-upOf9·,204.txt
m,236.txt
roughly15000Cases,65.txt
cervical,115.txt
eralphaSignalling,70.txt
unclear,172.txt
identified,153.txt
detectedThroughScreeningThroughSigns,91.txt
unusual,30.txt
greater,217.txt
investigated,173.txt
necessary,207.txt
comparison,21.txt
complex,141.txt
chicagoStudy,54.txt
inverselyCorrelated,174.txt
post-menopausalWomen,57.txt
independentPrognosticFactor,238.txt
probe,116.txt
metastatic,199.txt
differentBreastCancerMolecularSubtypes,225.txt
whenGiven,102.txt
formOfApoptosis,173.txt
mostFrequentLateComplication,164.txt
imagery,114.txt
breastCancer,126.txt
unusual,139.txt
mistaken,194.txt
locoregionalDiseaseOfUnspecifiedLocation,1.txt
canDiagnosed,33.txt
prostateCancerSurvivors,179.txt
breastCancers,141.txt
involved,135.txt
locallyAdvancedBreastCancer,111.txt
referral,151.txt
skeletonOfNanoplatform,159.txt
unclear,46.txt
studiesFocused,71.txt
study,47.txt
course,67.txt
normalTissues,221.txt
nirProbe,223.txt
widelyKnown,72.txt
metastaticDisease,1.txt
trend,1.txt
only44Percecnt,109.txt
brca1Wild-typeCells,135.txt
canOnlyDiagnosedOnPresentationOfSymptoms,33.txt
disease,121.txt
estimated,26.txt
women,66.txt
detectionRate,241.txt
results,204.txt
severalTumorSuppressorGenesInLungCancerPatients,226.txt
developed,101.txt
included,147.txt
fastDayBefore,151.txt
responsible,136.txt
diagnosed,202.txt
it,41.txt
study,27.txt
patientEducationIdentification/reportingOfSideEffects,22.txt
mostPrevalentType,145.txt
mostCommonAgentsUsedInBreastCancerTreatment,142.txt
therapies,76.txt
thatReportedInLiterature,217.txt
advancedBreastCancerBearingMutationsInGenesInvolvedInPi3k/ark/mtorSignalingPathway,197.txt
relevant,5.txt
trendsInUkCancerIncidenceByCancerSite,115.txt
severe,46.txt
patientsWithMAmongThem,32.txt
newValue-basedHealthcareParadigm,207.txt
importantInsightsIntoDiagnosisOfPatientsWithDisease,131.txt
howeverNon-ideal,210.txt
presented,53.txt
quantified,244.txt
applicability,36.txt
adherenceToEhtAmongBreastCancerPatients,22.txt
kaplan-meierCurves,147.txt
crucialRole,58.txt
rare,121.txt
patientWithEarlyBreastCancer,122.txt
follow-upSchemes,188.txt
country,161.txt
addition,114.txt
breastCancerPatients,238.txt
impairedBaselineCardiacFunctionExperience,27.txt
unreported,73.txt
needs,23.txt
accurateDiagnosisOfBreastCancerSubtypes,192.txt
sparseCombinationOfRiemannianDictionaryAtoms,59.txt
60ControlPatients,16.txt
role,240.txt
used,173.txt
highestRateForUpperGastrointestinalCancers,160.txt
outcomes,182.txt
significantlyYoungerAge,110.txt
exceedinglyRare,216.txt
good,175.txt
achievedForHer2Status,236.txt
vitalRole,42.txt
breastTumor,134.txt
platform,157.txt
diagnosed,174.txt
higherRiskOfBleeding,160.txt
sequelae,76.txt
melatonin,151.txt
description,11.txt
tumorGrowth,211.txt
affected,118.txt
criticalRoles,211.txt
positive,124.txt
based,193.txt
bl1Cell,106.txt
options,109.txt
usuallyPerformed,34.txt
devastatingDiagnosis,76.txt
case-controlAssociationStudyForVariantsInCodingRegionsOf11HereditaryBreastCancerGenesIn7051UnselectedBreastCancerPatientsOfJapaneseAncestry,110.txt
cssBenefit,103.txt
cyanosis,65.txt
mostCommonAdultCancersInKenya,158.txt
levels,70.txt
sometimesMistaken,194.txt
genes,110.txt
efficacy,60.txt
1YearTo5Years,147.txt
scPhenotype,156.txt
overviewOfAbbreviatedBreastMriProtocols,207.txt
preliminaryGroupOfCtibl,26.txt
eukaryoticTranscriptome,137.txt
hasAssociated,97.txt
study,153.txt
study,236.txt
identified,92.txt
immediateUnmetNeedInClinicalPractice,14.txt
advancedBreastCancer,100.txt
5-yearResultsOfPhase3Isg23-01Trial,204.txt
associated,66.txt
singleSmallIncision,122.txt
maySteps,31.txt
determined,238.txt
diverseMalignantTumors,106.txt
personalizedFollow-upSchemes,188.txt
sufferingFromWoman'sDisease,177.txt
differentSubtype,102.txt
evenAdjustedForKnownPrognosticFactors,86.txt
hasAssociatedWithPoorCancerScreeningUptake,75.txt
potentiallyCurativeRegimensOfCancerChemotherapy,46.txt
betterResults,79.txt
water,173.txt
diagnosisOfBreastCancer,58.txt
isIdentified,76.txt
49CedmCasesCollectedFromMayoClinic,101.txt
initiationOfPromptTherapy,39.txt
indicated,232.txt
needed,157.txt
selectPatientPopulations,76.txt
prominent,244.txt
positive,12.txt
riskFactors,164.txt
252Percecnt,111.txt
follow-up,188.txt
91Percecnt,86.txt
different,119.txt
growing,72.txt
twoUncommonCasesOfDelayedBreastCancerRelapses,17.txt
threeYearsBeforeAge64Years,33.txt
mostEuropeanCountries,79.txt
factorsRelatedToPresenceOfMetastaticDiseaseAtDiagnosis,1.txt
peopleWithDiagnosisOfCancer,186.txt
thereforeUrgentlyNeeded,159.txt
netherlandsCancerRegistryOf37230PatientsWithEarlyBreastCancer,188.txt
visualizedTheranosticsOfTumors,28.txt
significanceLevel,47.txt
pattern,93.txt
used,184.txt
downregulated,131.txt
contrastRatio,36.txt
continuousPatternOfRelapse,93.txt
itsImportantRoleInEtiologyOfManyDiseases,95.txt
treatedWithIntraperitonealInjectionFor30Days,82.txt
type,59.txt
negativeIndicator,123.txt
trendForLessRadicalSurgicalApproachesInBreastCancer,203.txt
access,187.txt
patients'Self-monitoring,22.txt
predominantlyCystic,43.txt
OS,103.txt
earlyBreastCancerDiagnosisOfBreastCancerRisk,226.txt
approximately75PercecntOfBreastCancers,42.txt
twoCasesOfMimicsOfBoneMetastasis,38.txt
utilized,11.txt
healthBehaviours,129.txt
fourGroups,183.txt
performed,194.txt
pathologyForFurtherFollow-up,10.txt
followed,66.txt
combination,142.txt
riskFactorForLung/bronchusCancer,118.txt
hypomethylated,58.txt
x-rayMammography,144.txt
humanBiofluid,234.txt
CTIBL,26.txt
thenExploredByRocheCobasE601,206.txt
drugs,201.txt
value,140.txt
lossOf020Quality-adjustedLifeYears,33.txt
related,58.txt
significantlyHigherPcrRatesThanPatientsWithLuminalTypes,102.txt
patient,139.txt
vap-1Staining,246.txt
positiveForGata3In93PercecntIn78PercecntOfCases,12.txt
earlyBreastCancer,80.txt
about30Percecnt,213.txt
differentOss,86.txt
year,197.txt
excision,37.txt
active,129.txt
vap-1ImmunohistochemicalStaining,246.txt
results,33.txt
Uganda,161.txt
theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulationsOfBreastCancer,218.txt
disseminatedDisease,121.txt
results,134.txt
thanCapecitabineGroup,196.txt
newOpportunitiesForDevelopmentOfNovelTherapeuticStrategies,3.txt
onlyWomen,174.txt
used,102.txt
decreased,66.txt
recurrence,147.txt
proposed,121.txt
patterns,111.txt
similar,69.txt
tightDoctor-patientCollaboration,231.txt
observed,4.txt
withFourier-domainReconstruction,36.txt
area,9.txt
analyzed,4.txt
breastCancerTissue,48.txt
multiplexedAssayForDetectionOfAutoantibodiesInCanineTumours,44.txt
presentStudy,130.txt
world,42.txt
breastCancer,25.txt
isReplaced,143.txt
breastCancerGeneticsInKenya,158.txt
acquisition,34.txt
hormoneReceptor-positiveBreastCancer,216.txt
irregularHyperintenseLesionInT2InLeftParietalRegion,97.txt
stat1RecruitmentToEralphaPromoterRegion,70.txt
associationOfPcdh10Methylation,185.txt
literature,89.txt
variedDegreesOfStructuralComplexity,181.txt
childHealth,174.txt
subgroupOfMacroprolactinomas,57.txt
reductionOfFpsFrom085002Fp/imageForMias,49.txt
averageOf425±496Ctcs/2Ml,178.txt
clinocopathologicOfPi3k/akt/ptenPathwayInMoroccanTripleNegativeBreastCancerPatients,171.txt
oneYear,139.txt
associations,68.txt
primaryPurposeOfPeriodicMammogramsInScreeningProgramsIs,30.txt
mriProtocols,207.txt
varyingAmountsOfSolidComponents,43.txt
given,49.txt
featureFactorsOfPrss,72.txt
oneFamilyAffectedByCs,85.txt
analysis,2.txt
prognosesOfYoungMenWithBreastCancer,103.txt
hasIncorporated,219.txt
coxRegressionAnalyses,179.txt
4Domains,111.txt
largeCohortOfPatientsWithPituitaryAdenomasInOutpatientClinic,202.txt
120Patients,16.txt
superiorVenaCavaSyndrome,65.txt
patientsWithBreastCancer,38.txt
proliferation,26.txt
canDifficult,107.txt
trend,203.txt
patterns,115.txt
diagnosisOfResponseToTreatment,134.txt
breastCancerTissues,18.txt
chapter,225.txt
documented,99.txt
earlyCancerDiagnosis,44.txt
thusPresented,53.txt
risk,25.txt
used,238.txt
used,7.txt
t-MDS,191.txt
hasEstablished,51.txt
themselves,138.txt
theirOwnParticularity,100.txt
contrastAfterInjection,210.txt
cancerSurvival,123.txt
similar,180.txt
immunohistochemicalMarkers,12.txt
tumor,191.txt
invasiveBreastCancer,187.txt
involved,70.txt
product,157.txt
appliedTo70PatientsWithUnilateralRl,19.txt
mightCrcMarkers,206.txt
twoYears,6.txt
HR,66.txt
collectedFromElectronicHealthRecord,163.txt
triple-negativeBreastCancers,141.txt
prognostic,246.txt
hasProposed,105.txt
collected,47.txt
tumorSuppressorMir-10aInCells,244.txt
study,14.txt
patient'sOutcomeOverCosts,207.txt
probablyTranscriptionalActivation,105.txt
protected,161.txt
used,142.txt
diagnosisAccuracy,192.txt
glycosylationOfMembraneTypeMr,132.txt
heterogenous,200.txt
robust,236.txt
promising,189.txt
invasiveBreastCarcinoma,61.txt
expressed,221.txt
mice,46.txt
CLP,89.txt
fewPercentOfWomen,213.txt
neoplasms,44.txt
concerns,139.txt
howeverGreaterforPatientsTreatedInAlmatyCity,145.txt
diagnosis,180.txt
context,199.txt
timingOfChemotherapyForBreastCancersWithDifferentMolecularBackgrounds,102.txt
synchrotronRadiation,224.txt
significant,234.txt
womenWorldwide,157.txt
theirContraceptivePreferences,96.txt
observed,95.txt
training,190.txt
metforminTreatment,153.txt
cancer,228.txt
associationBetweenNsaidsExposureInFemalePatientsWithAd,66.txt
macroadenomas,57.txt
effectOfDdtSpraysOnBreastCancerIncidenceRate,24.txt
women,141.txt
severeSideEffects,159.txt
cure,23.txt
overallLowOfSixCirculatingMirnas,120.txt
physicallyActive,129.txt
couldDetectedByMammographyBySelf-detection,188.txt
China,100.txt
likely,66.txt
30TBreastMagneticResonanceImagingExaminations,150.txt
hasUsed,76.txt
localTherapyOfBreastCancer,143.txt
roleOfSupportOfferedByVirtualCommunitiesToBreastCancerPatients,35.txt
mortalityRate,58.txt
non-ideal,210.txt
drugResistanceOf,125.txt
successfullyUsed,211.txt
necessary,102.txt
inPaperUsed,114.txt
functions,18.txt
rare,93.txt
protected,93.txt
resultCompatibleWithMetastasisToOrbit,121.txt
nationwideRegistries,133.txt
estrogenReceptor,168.txt
performed,235.txt
generalPopulation,102.txt
about1Year,191.txt
time-varyingPost-diagnosisLow-doseAspirinUse,133.txt
sensitivityOfMda-mb-468ToChemotherapeutics,106.txt
balb/cNudeMiceBearing,205.txt
womenInWorld,100.txt
role,125.txt
strong,218.txt
understood,195.txt
breastCancerRisk,219.txt
firstFiveFacebookOpenBreastCancerGroupsInYear2016,35.txt
furthermoreDiagnosedWithPaAtEarlierAgeThanPatientsWithNegativeFamilyHistory,202.txt
efficientlyCross-linked,211.txt
sentinelNodeBiopsy,143.txt
inMultivariateModelsRelatedToPerformanceStatus,4.txt
canStressfulToPatient,34.txt
unclear,75.txt
breastCancer,38.txt
advancedComputationalSystems,62.txt
negativeEffects,7.txt
spindleCells,107.txt
pulmonaryEverolimusSideEffects,104.txt
forPrecisionResectionUrgentInFieldOfDiagnosis,29.txt
onlyIndicative,51.txt
drugDecay,198.txt
accuracy,113.txt
effect,153.txt
ideallyPlaced,92.txt
influenceOfSleepQualityOnPmInPatientsTreatedWithHt,228.txt
hasAchieved,49.txt
documentedAsImportantTumor-promotingAgentForSeveralHumanCarcinomasIncludingBreastCancer,99.txt
seen,191.txt
annexinV-fluoresceinIsothiocyanate/propidiumIodide,173.txt
groups,163.txt
assessment,107.txt
thusMeaningful,192.txt
burdenOfCervicalCancer,53.txt
her2Expression,159.txt
CK5,12.txt
discussed,225.txt
associationsOfPhysicalActivityInGlobalHealthInBreastCancerSurvivors,165.txt
differentialDiagnosisInPatientsWithHistoryOfBreastSurgery,220.txt
correlated,83.txt
public,108.txt
westernizedCountries,213.txt
stratification,167.txt
rareSubtypeOfDllWithLimitedDataOnPatternsOfFailure,93.txt
correlated,1.txt
feasible,207.txt
used,115.txt
2002,217.txt
particularlyPatientsWithDenseBreastTissue,155.txt
critical,70.txt
importantProblem,113.txt
collisionTumor,10.txt
noninvasive,116.txt
disease,109.txt
subgroupAnalysispleuroparenchymalAnomaliesRateDetectedOnF-fdgPet/ct,104.txt
underway,153.txt
necessary,32.txt
interval,108.txt
diffuse,31.txt
hasRecentlyProposedAsCrucialRegulator,105.txt
that,193.txt
intravenousAdministrationOfOsteopontin-750Probe,134.txt
byWhichObservedInNondestructiveWayThroughThermalAnalysis,7.txt
21Percecnt,191.txt
cause,191.txt
mappedToPatientPathway,92.txt
couldSutegorized,86.txt
role,11.txt
analyzed,103.txt
developmentOfManyMetabolicDisorders,95.txt
cancer,59.txt
rareComplicationMostCommonlySeenInPatientsPreviouslyTreatedForBreastCancer,149.txt
breastCancerCells,185.txt
investigate,41.txt
expression,82.txt
fieldOfMedicalImagesDiagnosis,83.txt
assessment,147.txt
impact,178.txt
found,183.txt
investigated,32.txt
breastImageneologicalSurveillanceBeginningAtAge,98.txt
resultsOfIndividualVdrPolymorphisms,95.txt
brcanessPhenotypeInBrca1Wild-typeCells,135.txt
appropriateQuality,53.txt
rare,220.txt
hasRecentlyDeveloped,15.txt
breast,179.txt
proteins,239.txt
effective,148.txt
substantialDelayFromDiagnosisToTreatment,94.txt
elderlyPatientWithRelapsedHer2,139.txt
manyWays,232.txt
mainlyEurope,26.txt
antihormonalTherapyForHormoneReceptor-positiveBreastCancer,216.txt
scalableIntervention,22.txt
RiskProtection,13.txt
used,160.txt
presence,216.txt
confirmed,173.txt
functionalizationStepsForRapidDetection,239.txt
recentlyHaveUsedAsBiomarkers,20.txt
regulationOfNras,18.txt
extremelyRare,232.txt
present,241.txt
found,217.txt
importantlyCouldPotentialDiagnosticBiomarkerInEthnicPopulation,13.txt
highMortalityRateForFemales,58.txt
0.46,4.txt
canDetectedInManyBodyFluidsIncludingSerum/plasmaSamples,226.txt
commonMalignantDisease,192.txt
handheldProbeCapable,116.txt
tumorGrowthInExperimentalModels,56.txt
consistentMass-spectralData,236.txt
major,223.txt
exactTest,89.txt
indicated,104.txt
related,30.txt
challenging,59.txt
pax6MethylationStatus,41.txt
understudiedPattern,152.txt
determined,102.txt
advantages,224.txt
malignancy,1.txt
additionallyCorrelated,83.txt
painless,32.txt
toxic,173.txt
hasValidatedDatabase,49.txt
prospectivelyFollowedFor3YearsSinceDiagnosis,129.txt
adverseEventsExceptDegreeI-iiBleeding,196.txt
detectionOfCancer,59.txt
hasFocusedOnTumourCellsPrimarily,233.txt
class,181.txt
alteredInHumanBreastCarcinoma,45.txt
inConclusionMajorHereditaryBreastCancerGenesIrrespectiveOfAgeAtDiagnosisInJapaneseWomen,110.txt
essential,228.txt
results,79.txt
breastCancerTissues,131.txt
importantOfSpc24ForClinicalTreatment,221.txt
theirExperiencesLivingWithSister,138.txt
parameters,170.txt
cause,45.txt
postponementVisiting,47.txt
field,101.txt
inOfGamma-ggtTransformedIntoNir-sn-nh,29.txt
outcomesAmongKoreanPatients,124.txt
featuresFromImages,83.txt
femaleSibling,138.txt
cancerCare,23.txt
solved,36.txt
firmlyPlaceWithRecentTrendsTowardDecreasedRatesOfRe-excision,143.txt
tomography,224.txt
tumor,159.txt
properAccessToDiagnosis,33.txt
shanxiProvinceOfChina,32.txt
imperative,228.txt
1999-2011,179.txt
howeverMuchLower,116.txt
study,89.txt
connection,68.txt
acid,234.txt
amongThemNewlyIdentifiedInStudy,132.txt
whenSuspected,80.txt
potentialTreatmentStrategyForEndocrine-resistantBreastCancers,70.txt
analysed,119.txt
monitoredOnDailyBasis,162.txt
certainCancers,164.txt
accessToReceptorAnalysesInCytosolAtDiagnosis,245.txt
expressionOf6CirculatingMirnasInOperablePatients,120.txt
standardMethodForEvaluationOfProposedPrognosticTumourMarkers,245.txt
melanoma,215.txt
observed,71.txt
confounders,200.txt
bleedingRisk,160.txt
feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling,220.txt
thereforeCentralTarget,42.txt
balfContentOfProgranulinIn46NsclcPatientsBeforeChemotherapy,48.txt
issues,143.txt
inNumericalSimulationsAccuratelyReconstructedWith90PercecntAccuracyUpToNoiseLevelOf50Percecnt,36.txt
betterDiagnosticAccuracyThanFfdm,101.txt
breastCancerTissues,81.txt
osteolyticLesion,166.txt
radiation,76.txt
populations,88.txt
Kiel,74.txt
divided,102.txt
associated,24.txt
ranging,35.txt
informationalNeedsByCancerType,23.txt
outcomes,124.txt
weak,154.txt
tool,136.txt
summarisedIn2018WorldCancerResearchFund/americanInstituteForCancerResearchReportGlobalPerspective,186.txt
nf-krab-inducedIncreasedExpressionOfCcnd1,82.txt
factor,238.txt
surgicalOptionsIncludingPreservationOfNippleAreolaComplex,109.txt
expression,105.txt
olderAdultsWith,201.txt
totalGroup,16.txt
riskOfOtherLongTermAdverseHealthSequelae,25.txt
importanceOfProactivelyAddressingFertility,230.txt
humanBody,7.txt
un-recognized,57.txt
retrospectiveStudyOfPatientsWithCa-vte,160.txt
known,225.txt
HeLa,130.txt
IC,181.txt
model,133.txt
detected,147.txt
important,95.txt
adjustingForPotentiallyConfoundingFactors,102.txt
breastCancerSubtypesa,102.txt
proteinS-100,97.txt
theirParticularity,100.txt
40Percecnt,187.txt
efficientlySynthesized,181.txt
haveIntroduced,207.txt
designed,126.txt
performanceEvaluation,114.txt
peakInRecurrenceRisk,188.txt
riskForRecurrence,22.txt
subset,183.txt
poorerPrognosisInPatients,77.txt
mammalianBrainTissues,137.txt
survivalDifferences,103.txt
ourExperience,222.txt
components,84.txt
healthySubjects,48.txt
diagnosticChallenge,31.txt
patient,197.txt
onlySubgroupWithProgesteroneReceptor,103.txt
riskOfDeath,22.txt
areaOfResidence,187.txt
aggressiveCourseOfHer2Cancer,139.txt
factors,165.txt
proteomeScaleWithHighSelectivity,211.txt
mostFrequentlyDiagnosedCancer,237.txt
similaritiesInInformationalNeedsByCancerType,23.txt
generalPopulation,243.txt
pi3k/aktKinasePathway,221.txt
negativelyCorrelatedWithLvef,163.txt
support,214.txt
similar,32.txt
4.71,129.txt
health,64.txt
mayDetected,104.txt
overPeriod2008-2012RegisteredInOlderAdultsInFourPopulations,161.txt
similar,160.txt
variousStimuli,84.txt
mostCommonCancer,141.txt
betterOutcomes,182.txt
mustAddressed,138.txt
mostCommonCancerInWomen,193.txt
important,192.txt
immune-mediatedCancer-associatedDisorders,67.txt
cross-linked,211.txt
receiverOperatingCharacteristic,238.txt
inheritableBi-objectiveCombinatorialGeneticAlgorithm,20.txt
effects,82.txt
concomitantlyShouldAnalyzed,98.txt
moreAdvancedStages,187.txt
prognosis,80.txt
analyzed,138.txt
expectedInverseCorrelationOfSerumDdtsWithBmi,174.txt
associated,46.txt
lastFourDecades,115.txt
illiterate,108.txt
yetHasFirmlyEstablishedInClinicalPractice,51.txt
update,203.txt
influenceOfLifestyleFactorsOnPrognosis,112.txt
thereforeRequired,83.txt
theirLimitedAccess,211.txt
found,246.txt
understand,138.txt
Cells,135.txt
quality,245.txt
increasedContrast-to-noiseRatioForMonochromaticOverClinicalImagesForWell-definedPhantom,50.txt
recentYears,9.txt
itInvolvesInManyCrucialMetabolicProcesses,234.txt
canExtended,188.txt
hasApplied,142.txt
developmentOfLymphedema,19.txt
resectedPrimaryLungCancer,12.txt
associated,2.txt
histologicalStructureOfTumorTissues,162.txt
activity,209.txt
aboveConditions,137.txt
cancerTreatment,127.txt
underutilized,138.txt
available,151.txt
identificationOfPredictiveBiomarkersForSelectionOfOptimalTreatment,241.txt
cardiotoxicity,201.txt
signatures,218.txt
brainMetastasisFromPapillaryThyroidCarcinoma,73.txt
improvedDiagnosis,81.txt
cause,166.txt
768PercecntSamplesWithOverexpressionIn76Cases,128.txt
sample,51.txt
immunocaptureOfMarker,176.txt
diagnosisInMajorityOfInconclusiveCases,50.txt
malignancy,25.txt
associationStudy,110.txt
twoLargeBreastCancerDatabases,192.txt
statisticallySignificantValuesAt4Cells/7MlBlood,169.txt
utilization,213.txt
patientsWithHer2,102.txt
couldDetected,5.txt
approximated,86.txt
inspection,53.txt
sensitivityOf786PercecntRespectively,44.txt
challenges,211.txt
general,149.txt
sideEffects,151.txt
case,121.txt
influenceOfHealthLiteracyOnPathwayToCancerDiagnosis,75.txt
goodDiagnosticPerformance,194.txt
massSize,232.txt
breastCancer,131.txt
riskOfEndometrialPathologies,199.txt
dyspareunia,151.txt
recentlyDevelopedBreastImagingTechnique,34.txt
data,200.txt
changesInHealthBehavioursAfterBreastCancerDiagnosis,129.txt
type1Diabetes,95.txt
obtainedFrom66FemalePatientsWithMAtDifferentTimeIntervalsForEvaluationOfCtcsByFlowCytometry,169.txt
itsWidespreadUse,207.txt
performed,24.txt
howeverLargelyUnreported,73.txt
borders,94.txt
panelOf25GenesInvolvedInMechanismsOfTargetedTreatmentResistanceIn16PrimaryBreastCancersDevelopedDuringTreatment,241.txt
treatmentOfBreastCancer,42.txt
4,169.txt
RL,19.txt
diagnosis,12.txt
G,180.txt
better,196.txt
M,32.txt
hadDiagnosedWithBreastCancerAtEarlyAge,85.txt
recommended,188.txt
concerned,29.txt
theirCytotoxicityAgainstTwoHumanTumorCellLines,181.txt
specificCancerCell-relatedComponents,136.txt
11Days,108.txt
treatedWithCapecitabineMonotherapyAsThird-lineTherapy,196.txt
likely,145.txt
neurologicalDisorders,137.txt
effects,13.txt
potential,178.txt
nirLight,159.txt
inMarch2014BroadcastedAsPart,64.txt
well-establishedTreatment,126.txt
Barshi,108.txt
targetedImaging-guidedPhotothermal/chemoSynergisticTumorTherapyWithHighTherapeuticEfficacy,159.txt
itsRole,95.txt
an,120.txt
willTestedThroughEuropeanMyPersonalBreastScreening,79.txt
potentialBiomarkerForCancerDiagnosisThanMrnaBiomarkers,192.txt
township,24.txt
massInPosteriorFossaOfBrain,10.txt
southernPortuguese,1.txt
performance,194.txt
pax6OverexpressionIncreasingMmp2Andmmp9ExpressionAtMrnaLevel,41.txt
canClassifiedAsSoluble-proteinBasedImmunocytochemical,51.txt
binding,9.txt
histopathologicFeatures,149.txt
resultsOfStudy,204.txt
thusCritical,70.txt
criticalImplicationsForTherapeuticDecision-makingInUrothelialCancer,60.txt
reference,100.txt
survival,22.txt
absorptionImagesAcquiredWithMonochromaticX-raysFromCompactSynchrotronSourceBasedOnInverseComptonScattering,50.txt
414Percecnt,108.txt
highlyPenetrantGenes,110.txt
cancerClassification,170.txt
sixteenRegionsOfKazakhstan,145.txt
infection,164.txt
uncommon,217.txt
tumorSuppressorGene,185.txt
hasInconsistent,212.txt
analysis,37.txt
benign,144.txt
876PercecntRespectively,147.txt
size,43.txt
patientSelectionForNon-pcosReferenceCohort,117.txt
similaritiesOfInformationRequired,23.txt
vitalRole,125.txt
pregnancyFrom1959To1966,174.txt
onEsophagogastroduodenoscopyIdentifiedInAntrum,6.txt
nausea,76.txt
consistent,208.txt
characterized,90.txt
chemotherapy,227.txt
analyzed,217.txt
particular,218.txt
sameRangeAsCasesWithoutWavelength-dependentMeasurementErrors,116.txt
expected,194.txt
diagnosisOfEstrogenReceptor,197.txt
associated,172.txt
strongAssociationBetweenRs5743810AgainstRiskInSaudiArabianWomen,13.txt
preciseToolForTargetedTreatmentOfCancerIncluding,136.txt
pcosGroups,117.txt
presenceOfTendinopathy,216.txt
hasSuggested,243.txt
type160Patients,47.txt
evolveTowardLessSurgery,143.txt
analyzed,147.txt
tissueBiopsy,83.txt
made,216.txt
preventionOfBreastCancer,219.txt
240Months,119.txt
consistent,240.txt
risk,117.txt
successfulQuantificationOfCa15-3InSerumSamplesFromCancerPatients,176.txt
Ontario,91.txt
empiricalTreatmentsBasedOnClinical-pathologicalCharacteristicsToUseOfTargetedApproaches,241.txt
statisticallyCorrelated,1.txt
secondaryLymphoidTissueDevelopmentOfLymphocytesWithinMicrocompartmentsOfTissue,48.txt
SRS,73.txt
48Years,152.txt
ourPreviousWorkRegardingToPropertiesOfPluronicsWithDifferentPhotosensitizerForPhotodynamicTherapy,14.txt
shouldPerformedInPediatricPatients,232.txt
activityOfCellProliferationInBreastCancerCells,18.txt
18f-fluoro-deoxy-glucoseCombined,104.txt
shouldAnalyzed,98.txt
threeKindsOfAlgorithms,170.txt
sensitivity,236.txt
decreasesInMortalityRates,136.txt
howeverHampered,206.txt
obtainedFromMedicalSpecialists,69.txt
second,202.txt
comparisonOfPredictedIncidenceOfBreastCancerWithActualIncidenceInPopulation-basedStudies,21.txt
apoptosis,244.txt
essential,39.txt
inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer,142.txt
sensitivityAnalysesresults,69.txt
safety,196.txt
determine,27.txt
forWomenWithBreastCancerMayMoreFeasible,227.txt
cancerGenomeAtlas,20.txt
oneYearOfDiseaseControlWithoutDeteriorationInHerEjectionFraction,139.txt
component,221.txt
26894Ca-vtePatientsTreatedWithAnticoagulants,160.txt
addition,206.txt
brcanessPhenotype,135.txt
selectedPopulationsOfAfricanPatients,88.txt
analysis,190.txt
fundamentalComponentsOfTumorMicroenvironment,84.txt
time,47.txt
firstCaseOfGaslessRobot-assistedNipple-sparingMastectomyInPatientWithEarlyBreastCancer,122.txt
virtualRecombinedImagesFromLeImages,101.txt
imaging,134.txt
recentYears,74.txt
determine,182.txt
generalPopulation,160.txt
trueRisk,115.txt
breastCancerAged,103.txt
essentialRole,226.txt
period,1.txt
inStudyFusedWithMouseMyelomaCellLineSp2/0InPresence,154.txt
mitoticExitOfPtx-pretreatedCells,198.txt
howeverWidelyUnderstood,195.txt
primaryTumor,241.txt
manyResearchers,114.txt
mostCommonCancer,136.txt
measured,244.txt
contrast,105.txt
developed,235.txt
oncogenes,3.txt
PI3K/AKT/mTOR,241.txt
preventionOfChemotherapy-inducedNeuropathy,46.txt
transferable,135.txt
lumbarSegments4-6,46.txt
sensitivity,106.txt
diagnosisOfCancer,97.txt
peripheralBlood,154.txt
caseOf39-year-oldManPresentedToUsWithMultipleSuutaneousLesionsOverChest,215.txt
largestCancerInformationWebsite,23.txt
markedlyDownregulated,172.txt
currentCancerResearch,127.txt
therapeuticEffectsInBreastCancer,82.txt
outcomeInLymphedemaPatients,151.txt
mostLikelyParaneoplastic,67.txt
challenge,120.txt
based,49.txt
activation,77.txt
expressionOfMir-511InBreastCancer,131.txt
shallow-CNN,101.txt
cancerMolecularDiagnosis,234.txt
pediatricPatients,232.txt
hybridChemicalProteomicsApproachTermedByEngineeringSrcHomology2,211.txt
common,117.txt
urgentClinicalProblem,70.txt
firstTimeIn1984,97.txt
denseBreasts,210.txt
mostPrevalentTumorFollowedByLow-gradeBNon-hodgkinLymphoma,191.txt
severalOtherGenes,158.txt
novelTherapeuticBiomarkerForDiagnosis,130.txt
992Percecnt,39.txt
furtherFound,244.txt
highlyExpressed,132.txt
haveUsed,184.txt
featureMiningFromRois,49.txt
knownHeterogeneousDisease,11.txt
novelInsightsIntoEpigeneticEvents,41.txt
formulationOfEffectiveManagementPlanForAt-riskWomen,138.txt
reported,108.txt
PCOS,117.txt
a549Cells,172.txt
distributions,58.txt
data,161.txt
type,145.txt
capacity,53.txt
group,67.txt
westernBlotAnalysis,61.txt
evenSubgroupOfPatientsTreatedWithRituximab,93.txt
1722Comments,35.txt
3-timeAssessments,22.txt
hereditaryDisease,175.txt
survival,118.txt
variability,200.txt
evidenceOffer,186.txt
surgery,197.txt
oftenHypomethylated,58.txt
patients,147.txt
Carcinoma,90.txt
medical,65.txt
compared,175.txt
unclear,79.txt
successOfSymmetricPositiveDefiniteMatrices,59.txt
implications,60.txt
estimates,7.txt
complication,152.txt
used,133.txt
required,115.txt
particular,241.txt
significantChallenge,196.txt
women,231.txt
quality,100.txt
choiceOfImmunohistochemicalTechniques,74.txt
adultPatientsDiagnosed,75.txt
designed,218.txt
forRace/colorVariableEstimatedWithAdjustmentForStatus,187.txt
cancerSignaling,211.txt
activity,18.txt
determined,16.txt
cancer,39.txt
threeCases,216.txt
humanBreastNeoplasmsWithDeregulationOfSeveralMirnas,71.txt
associated,246.txt
significantlyLower,173.txt
patientsWithBreastCancerReceivingWithAnthracyclines,142.txt
essential,149.txt
access,33.txt
role,95.txt
needed,159.txt
mood,151.txt
modestAnti-tumorActivity,209.txt
OS,185.txt
imagingFeaturesOfCommon,166.txt
increased,130.txt
breastCancerDiagnosis,138.txt
largelyConsistent,208.txt
downregulatedIn,77.txt
qualityOfLife,237.txt
aiDiscontinuation,216.txt
modified,159.txt
upregulated,77.txt
suggested,113.txt
involved,56.txt
normalSamples,190.txt
cancerCareSystems,177.txt
couldConsidered,27.txt
sexualStigmatizationOfM,177.txt
inTotalMatchedToCasesOnBirthYear,174.txt
chronicDebilitatingLifelongComplication,19.txt
care,157.txt
breastCancer,225.txt
itsReceptorLocatedInManyCellsOfBody,95.txt
heterogeneousDisease,41.txt
performed,154.txt
associated,13.txt
unclear,189.txt
provedByExperimentalEvidence,77.txt
likely,187.txt
known,72.txt
those,182.txt
patientsWithHistoryOfTranstuzumab-inducedCardiacDysfunction,139.txt
affected,71.txt
furthermoreHaveSuggestedAsPotentialCirculatingNoninvasiveBiomarkersForEarlyDetectionOfGastricCancers,226.txt
haveProven,46.txt
size,232.txt
metformin,153.txt
shouldPerformedInAtRisk,80.txt
expressions,106.txt
improvementInClassificationOfMalignantLesions,116.txt
thereforeApplied,177.txt
applied,74.txt
breastCancer,3.txt
chosen,178.txt
comparedBetween2GroupstheApatinib,196.txt
overexpressed,70.txt
associationBetweenUseOfSelectiveEstrogenReceptorModulators,219.txt
bodyMassIndex,174.txt
1973To2014,118.txt
adequateSampleForAnalysisOfMolecularMarkersToGuidePatientsWithNon-smallCellLungCancerToAppropriateTargetedTherapies,51.txt
human,144.txt
methylSpecific-multiplexLigationProbeAmplification,41.txt
potentialMechanismForFoxc1-inducedMetastasis,105.txt
patientsOnAromataseInhibitors,151.txt
especiallyFrequentLateRelapsesInCnsBreast,93.txt
976PercecntSensitivity,236.txt
state-of-the-artImageAnalysisMethods,62.txt
occurrenceOfPolymorphisms,95.txt
accuracy,122.txt
nowAlsoWidelyUsed,143.txt
closelyAssociated,58.txt
forefront,120.txt
limitedPerformanceForWomenWithDenseBreasts,101.txt
mustIndividualized,231.txt
unilateralBreastCancer-relatedLymphedema,19.txt
prevalent,191.txt
breastCancer,61.txt
role,42.txt
proliferation,198.txt
hasPut,195.txt
replaced,143.txt
developmentOfSubsequentLung/bronchusCancer,118.txt
itsPerformance,194.txt
areUsed,210.txt
potentialTarget,131.txt
1Year,147.txt
randomlyDivided,162.txt
automaticIntraoperativeIdentificationOfBreastCancerMargins,83.txt
recommended,10.txt
evaluatedInVivo,134.txt
highlyEffective,22.txt
systems,62.txt
harmToHealthAmongRuralWomenWithIncrementalCost-effectivenessRatio,33.txt
genesInvolved,197.txt
1984,97.txt
obtained,176.txt
PAX8,12.txt
collected,119.txt
gender,179.txt
metastasesFromDistantPrimaryTumors,199.txt
itsMinimalSilverIonReleaseProfiles,210.txt
0.001,184.txt
improvement,116.txt
neededAcrossCareContinuumEspeciallyInLow-resourceSettings,157.txt
relatedResearchDataOfDiagnosisOfInoperableLocallyAdvancedBreastCancer,100.txt
consultations,91.txt
tissueTumors,72.txt
used,179.txt
forefrontOfResearch,120.txt
exon32OfMammalianTargetOfRapamycin,197.txt
mapped,92.txt
SVM,20.txt
progressionOfSeveralTypesOfNeoplasms,77.txt
complex,189.txt
structureChanges,163.txt
used,117.txt
diagnosisOfAcuteCoronarySyndromes,142.txt
pre,146.txt
shouldElaborated,231.txt
bl1-subtypeTriple-negativeBreastCancer,106.txt
widerPopulationOfPatients,135.txt
usuallyDiscoveredIncidentally,166.txt
survivalThanAdjuvantTherapy,102.txt
proposed,59.txt
saudiArabianWomen,13.txt
diagnosticAccuracy,101.txt
surgicalAccuracy,122.txt
moreDesirable,178.txt
management,139.txt
risksOfCancerInMutationsCarriers,98.txt
robustTechnology,236.txt
shouldGiven,161.txt
created,35.txt
tool,240.txt
lowRiskLesions,37.txt
iU22,194.txt
collected,23.txt
calculated,114.txt
multipleBiologicalRolesIncludingParticipationInImmunosuppressiveStudies,71.txt
reductionOfRelapse,93.txt
thusPotentialTherapeuticTarget,131.txt
nowGreater,217.txt
typicallyBilateral,43.txt
costOfMriExamination,207.txt
investigated,89.txt
metastaticAdenocarcinomaFeatures,215.txt
dopamineAgonist,57.txt
role,189.txt
serious,233.txt
unclear,244.txt
hasPutOnIntrinsicSubtypingBasedInPresenceOfClassicalImmunohistochemistry,195.txt
downregulated,137.txt
sw-22,209.txt
cells,205.txt
oftenRelated,30.txt
included,2.txt
16PrimaryBreastCancers,241.txt
MORC4,81.txt
urgent,29.txt
growth,81.txt
frequentlyDetected,199.txt
harmfulorHarmlessTissues,144.txt
gtpaseInBreastCancerCells,18.txt
mda-mb-231Cells,105.txt
theirRelatedMarkersAtDifferentPointsOfChemotherapyRegimensInMetastaticBreastCancer,169.txt
content,50.txt
breastCancer,203.txt
features,191.txt
positive,67.txt
identified,238.txt
deep-CNN,101.txt
Kazakhstan,145.txt
thereforeHasAppliedToEarlyIdentification,142.txt
ODV,159.txt
multicenterStudy,236.txt
hypothesis,174.txt
theirBeliefsRegardingCancerCausation,138.txt
previousStudies,208.txt
survivalVariance,102.txt
medications,66.txt
postmenopausalwomen,146.txt
promising,228.txt
dose-dependentReductionInBrca1Levels,135.txt
receivedWithoutSurfaceModification,176.txt
howeverHaveClarified,131.txt
alsoAssessedByQrt-pcr,169.txt
denseBreasts,148.txt
newDesignDouble-layerCapacitors,176.txt
developmentOfNewDrugs,100.txt
trastuzumabTherapyForBreastCancer,27.txt
eventHybridizationOfMirna-21Biomarker,235.txt
haveYetProven,46.txt
secondaryConfirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging,134.txt
shouldConsideredInEventOfAbnormalImagingFindings,232.txt
breastCancer,58.txt
38Months,121.txt
adulthood,24.txt
studied,2.txt
estrogenReceptor,21.txt
treatmentTherapy,193.txt
featureSelection,170.txt
connected,229.txt
theirCare,182.txt
valueOfErbeta-targetedTherapies,140.txt
riskOfBreastCancerInAdulthood,24.txt
itsPoorPrognosis,127.txt
variousArtifactsIntroducedDuringSlidePreparation,59.txt
rituximab,67.txt
EMT,130.txt
case,215.txt
surgery,92.txt
greatPotentialInDiagnosisTherapyOfCancers,55.txt
haveProducedInLaboratories,154.txt
familyImpact,138.txt
portugueseWomen,1.txt
prognosticFactorsOfCancerProgression,48.txt
increasedMalignantPotential,45.txt
emergingPublicHealthProblemInLowCountries,108.txt
potential,55.txt
betterOs,103.txt
advancedBreastCancer,197.txt
recentlyDiagnosedBreastCancer,146.txt
especiallyPost-neoadjuvantTreatment,92.txt
generalBreastCancerPopulation,152.txt
haveDeveloped,136.txt
findings,2.txt
potentialApplicationForDiagnosisOfCancerInFuture,18.txt
reduction,135.txt
processing,144.txt
descriptive,39.txt
conducted,70.txt
expressed,128.txt
bevacizumab-relatedCardiotoxicity,6.txt
breastCancerRisk,158.txt
normalDucts,246.txt
evaluation,167.txt
breastCancer,32.txt
twoCasesOfCavernousMalformationFormationYears,73.txt
significantlyAssociatedWithSeveralHealthOutcomesForTargetChild6YearsLaterIncludingCertainInfections,183.txt
diagnosis,7.txt
similarSeriousAdverseEvents,196.txt
skeleton,159.txt
this,24.txt
familyMember,202.txt
rolePlayedByPdgfFamilyMembersInNormalDevelopmentOfBreastTissueDespiteItsPotentPro-lymphangiogenicEffects,99.txt
thereforeVeryPromisingStrategy,159.txt
increase,24.txt
fundamental,166.txt
cell-killingEffectInTriple-negativeSubtypeMda-mb-231Cells,205.txt
country,147.txt
heartFailure,51.txt
perceivedWorkAbility,2.txt
developed,178.txt
haveAssociated,109.txt
correctDiagnosis,166.txt
currentTherapiesAvailable,76.txt
theirHealthBehaviours,129.txt
heterogeneousDisease,221.txt
RFFS-GS,170.txt
haveObserved,190.txt
ronReceptorTyrosineKinase,128.txt
promisingShort-termStrategiesPriorToTreatmentAdministration,227.txt
0.02,4.txt
10-yearBreastCancerSurvival,187.txt
properties,63.txt
protected,105.txt
tumorGrowth,244.txt
life,202.txt
potentialOfAionAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis,210.txt
female-specific,119.txt
patients,145.txt
highVolumeAcademicCenters,182.txt
mostCommonNeoplasms,44.txt
heterogeneous,41.txt
itsUse,207.txt
heartFailureParticularly,51.txt
followed,129.txt
found,244.txt
3PreviousMalignancies,191.txt
ca15-3ByCmia,16.txt
HER2,102.txt
case,220.txt
n-typeVoltage-gatedV-gCalciumChannelBindingAntibodies,67.txt
greaterthan1500Pg/ml,51.txt
hasFound,208.txt
considered,114.txt
collectionOfSignsResultingFromObstructionOfSuperiorVenaCavaIncludingSwellingOfUpperBodyOfHead,65.txt
determined,188.txt
higher,18.txt
mutationsCarriers,98.txt
thenLinkedToTownshipFemaleBreastCancerIncidenceRateIn2000s,24.txt
hasUsedInLeukemia,76.txt
protected,33.txt
suppressionOfCellSurvival,77.txt
tumorSuppressorFunctionOfP53InPathogenesisOfBreastCancer,3.txt
developed,55.txt
731Percecnt,1.txt
investigatedOnly,108.txt
fiveYearsPosttreatment,217.txt
delivery,22.txt
currentEvidenceOnEfficacyOfHer2-targetedTherapiesInOlderAdultsWith,201.txt
secretion,82.txt
drugExtravasation,164.txt
comparableToContrast-enhancedMriInTermsOfSensitivityAtFractionOfCost,34.txt
theirVariousness,206.txt
includedInStudy,66.txt
place,74.txt
significantCausativeGenes,110.txt
promisingNon-invasiveReal-timeSurrogatesForCancerDiagnosis,239.txt
whenSevere,46.txt
rare,149.txt
benefitOfProtectionAgainstCardiovascularEventsWithPotentialReductionInBreastCancerRisk,219.txt
alsoAssociated,65.txt
unusual,67.txt
necessary,104.txt
questionnaireBasedOnAnderson'SdelayModel,47.txt
outcome,149.txt
moreRefinedStratificationThanAnatomicStageAlone,167.txt
tripleAssessmentFollowed,107.txt
potentialClinicalBiomarker,106.txt
performed,219.txt
exit,198.txt
similarToThatReportedInLiterature,217.txt
estrogen-receptorAmongOtherMarkers,236.txt
oneRegion,79.txt
accuracy,83.txt
widelyUtilized,11.txt
womenWithG,180.txt
moreIntensiveFollow-up,188.txt
possibilityOfEarlyDetectionOfRiskOfOsteoporosisToItsDevelopment,95.txt
50,188.txt
breastCancer,214.txt
policyActions,157.txt
CNVs,192.txt
novelNear-infraredNirFluorescentProbe,223.txt
breastCarcinoma,246.txt
necessary,142.txt
ratio,50.txt
incidenceRates,115.txt
properties,21.txt
hasIncorporatedIntoClinicalPracticeForOver100YearsAtLowCost,219.txt
surgery,76.txt
twoMoieties,29.txt
assessedPreoperatively,109.txt
cause,65.txt
used,83.txt
hasProven,95.txt
withBetterDrugDeliveryPotentialOfNon-sphericalShapesHaveRecentlyInvestigated,9.txt
stageIi,39.txt
used,216.txt
known,214.txt
found,66.txt
associated,174.txt
testingDataSet,170.txt
widelyExpressed,128.txt
project,72.txt
breast,47.txt
tumorEasily,26.txt
elusiveToTargetedTherapies-theTriple-negativeBreastCancer,127.txt
lapatinibCombined,139.txt
moreoverPoor,7.txt
usuallyAssociated,168.txt
independent,246.txt
associationsOfFactorsWithLocoregionalAtDiagnosis,1.txt
apoptosis,136.txt
veryRareClinicalEntityWithOnlyFewCasesHavingReportedToDate,220.txt
isReplacedWithRadiotherapyInSituations,143.txt
example,226.txt
known,245.txt
regulated,9.txt
developmentOfBreastCancer,225.txt
development,21.txt
conclusionsInPractice-basedSampleOfCa-vtePatientsAssociatedWithSimilarBleedingRisksToWarfarin,160.txt
future,18.txt
base,225.txt
cystic,43.txt
evidence-basedDecision-makingForPopulation,201.txt
positivelyAssociated,246.txt
oncogene,130.txt
observed,226.txt
MEDLINE,219.txt
similarlyInPancreaticCancersHaveSuggestedAsDiagnosticBiomarker,226.txt
oneRandomlyAssignedToAxillaryDissection,204.txt
group2,180.txt
commonCauseOfMorbidity,17.txt
flowCytometry,154.txt
invitedInputFromExpertsInSpecificAreas,92.txt
thenDefinedInReproductiveYears,98.txt
90PercecntOfPatientsWithRecurrence,147.txt
patients,200.txt
cardiotoxicityOfHer2-targetedDrugs,201.txt
375Percecnt,115.txt
known,195.txt
whereFacilitatedBySurfaceModificationOfNps,9.txt
found,110.txt
geneticMalignancyPredispositionSyndrome,72.txt
included,93.txt
expressionOfOtherBiomarkers,88.txt
C,133.txt
LVEF,27.txt
mustIndividualizedWithEmphasisOnOptimalCareOfMother,231.txt
broadcasted,64.txt
less-effectiveChemotherapyAgents,46.txt
hampered,206.txt
life,28.txt
cancerPatients,48.txt
third-lineTreatmentForAdvancedTriple-negativeBreastCancerthisRetrospectiveStudy,196.txt
understudied,152.txt
orderOfAppearanceFrequency,23.txt
treatmentOfTriple-negativeBreastCancerWithConventionalChemotherapeuticAgents,125.txt
report,40.txt
lung/bronchusMalignancies,118.txt
discovery,240.txt
anxiety,80.txt
oxphosTranscriptionalResponse,153.txt
cycle,84.txt
aberrantExpressionOfBIn21PercecntRespectively,191.txt
oneExtraVisit,188.txt
subsequentCancerCounselingOfFemaleSurvivors,118.txt
member,48.txt
decreasedGrowth,81.txt
historyOfBreast-conservingSurgery,220.txt
strongFamilyHistoryOfCancer,202.txt
canCategorizedIntoSubtypesOfLuminalA,192.txt
lessVisits,188.txt
inTotalDiagnosedUnderAgeOf50,174.txt
systemicChemotherapy,6.txt
earlyStage,238.txt
inclusions,36.txt
phosphorylation,229.txt
migrationAbilitiesOfHelaCells,130.txt
associationBetweenRace/colorInWomenWithBreastCancer,187.txt
youngMexicanWomen,96.txt
added,176.txt
abundantlyPresent,137.txt
treatmentBenefitWithTrastuzumabTherapyForBreastCancer,200.txt
breastCancerImagingSetting,36.txt
required,34.txt
proposed,192.txt
12EventsAmong121Patients,147.txt
breastCancer,151.txt
their,231.txt
nature,43.txt
falsePositives,49.txt
particularEmphasisQuantifying,11.txt
microscopicImages,175.txt
zebrafishTumorModel,105.txt
combinationsOfInductionInBrca1Wild-typeTripleNegativeBreastCancer,135.txt
panel,154.txt
lymphaticInvasion,246.txt
alsoAssessed,169.txt
risk,188.txt
number,193.txt
confirmed,135.txt
earlyDetectionOfSeveralCancerTypes,226.txt
her2Overexpressing,32.txt
prognostic,169.txt
treatmentMoreAccessibleToBreastCancerPatients,108.txt
women,110.txt
blood,154.txt
reviewed,72.txt
applied,144.txt
characteristicsLikeCapacityForInvasion,41.txt
consistentWithBreastCancerCellResultsSignificantlyInhibited,221.txt
associated,95.txt
lowCountries,33.txt
riskStratification,218.txt
objectives,80.txt
tumorNecrosisFactor,82.txt
relevant,96.txt
firstSymptom,47.txt
95PercecntCi646-779Percecnt,200.txt
nanoparticels,159.txt
visualInspection,53.txt
occurrenceOfTumors,206.txt
levels,153.txt
breastCancerConfinedWithinMammaryDuctsSurrounded,37.txt
255Months,72.txt
sensitivity,83.txt
matthewsCorrelationCoefficientOf8038Percecnt,20.txt
functionality,221.txt
urgent,70.txt
neoadjuvantAnti-her2Treatment,139.txt
from33ObservationalStudiesExposedToTrastuzumabTherapy,200.txt
infraredFluorescentImagingInTripleNegativeInVitro,134.txt
theirQuestionableImpactOnMortalityOnIncidenceOfAdvancedTumors,79.txt
course,139.txt
trastuzumabTherapy,27.txt
estimated,187.txt
cancerManagement,41.txt
weakToStrongReactivityToOtherCellLines,154.txt
mostFrequentCancer,159.txt
moreEasilyHypomethylated,58.txt
areInvestigated,207.txt
clinicalSetting,184.txt
inflammatoryDiseases,82.txt
treatment,73.txt
severalObjectives,80.txt
risk,98.txt
PFS,168.txt
lower,162.txt
50PercecntRelapsedTissues,241.txt
hormoneReceptor-positiveTumors,22.txt
cancerCareNetwork,5.txt
roleOfPdgf-b/pdgfr-betaAxisInRareTypesOfBreastCancers,99.txt
hazards,160.txt
rare,215.txt
OS,190.txt
NCAM1,154.txt
higherRisksOfTreatmentDelays,145.txt
required,83.txt
limitations,36.txt
tumorSites,23.txt
breastCancer,21.txt
Kenya,158.txt
potentialTreatmentStrategy,70.txt
greaterthanorequalto10PercecntReductionInLvef,27.txt
significantlyCorrelatedWithOverallSurvival,246.txt
risingTrendInMajorityOfLmics,53.txt
itEffects,76.txt
howeverKnown,245.txt
proportion,163.txt
discussed,184.txt
generallyFibrosis,217.txt
copyright,135.txt
field,170.txt
visits,80.txt
pharmacokineticProperties,209.txt
employed,184.txt
logisticregressions,145.txt
clearEvidenceForbenefitsOfTanUsageInBreastCancerClassification,40.txt
developmentOfBrainCancers,243.txt
enhanced,130.txt
pain,217.txt
shouldProceede,80.txt
detected,91.txt
value,12.txt
expressed,140.txt
earlyDiagnosis,84.txt
goodCorrelationBetweenErAnalysedWithCytAtDiagnosisAnalysedWithIhcInArchivedFfpeTissueFromSameTumour,245.txt
bayesianNetworkMeta-analysis,237.txt
lesion,121.txt
recentPatternsInIncidenceRatesForMajorCancerSitesInAdults,161.txt
mice,244.txt
relativelyGoodPrognosisWith5YearOverallSurvivalOf88Percecnt,80.txt
found,99.txt
17Years,174.txt
quantitative,36.txt
cellCycleRegulators,136.txt
hasDeveloped,15.txt
MP,177.txt
usuallyLong-term,57.txt
part,69.txt
metastaticBreastCancer,169.txt
recognized,132.txt
2651StudiesIdentified,200.txt
hasReported,18.txt
users,66.txt
survivalRatesOfLungCancerContinue,76.txt
roleOfEstrogens,243.txt
hospitalFromJanuary2016ToFebruary2017,196.txt
taiwanLongitudinalHealthInsuranceDatabase2005,66.txt
breastCancerCellMigration,87.txt
regulationOfEnergyMetabolism,95.txt
effectsOfPcosOnRisksOfGynecologicCancer,117.txt
detectionOfMicrocalcificationInMammograms,113.txt
moreImportantlyCanNowComplementedByEmergingDeepLearningTechniquesForFurtherProcessAutomation,62.txt
known,45.txt
hemorrhagicEnlargement30YearsAfter,73.txt
heterogeneousDisease,120.txt
modified,92.txt
neonatalOfRetrospectiveCohortOfPregnantWomenWith,180.txt
cancer,141.txt
cellMigration,105.txt
percentage,57.txt
obtained,169.txt
subsequentMalignancies,118.txt
breastCancer,218.txt
significant,72.txt
able,55.txt
inconsistentResults,133.txt
mitosis,198.txt
AS,149.txt
anticipated,167.txt
patientsWithProstateCancer,95.txt
independent,169.txt
theirInterestingBiologicalActivity,181.txt
sites,107.txt
survival,77.txt
pi3k-aktSignalingPathway,244.txt
reverseActiveLearningForClassificationOfHealthyBreastTissue,83.txt
65Months,86.txt
recurrence,22.txt
bilateralBreastLumps,107.txt
MortalityRates,136.txt
125DogSeraSamplesIncluding75MammaryTumourSera,44.txt
impactOfStableKnockdownOfSmarcad1OnHumanBreastCancerCellProgression,87.txt
cancer,237.txt
120BreastCancerPatients,22.txt
mostPowerfulTool,113.txt
tumorSamples,211.txt
registered,75.txt
risk,199.txt
differentmethodsOfSelf-treatment,47.txt
resultOfPreviousOrbitalBiopsy,121.txt
quality,151.txt
roughly15000CasesPerYear,65.txt
attention,42.txt
cancer-relatedDeathsAmongWomen,45.txt
sufficient,244.txt
moreoverStronglyRecommended,4.txt
interest,109.txt
formed,210.txt
body,26.txt
poorPrognosis,189.txt
hdgcTestingCriteria,89.txt
20PercecntForGata3,12.txt
hotIssueInFieldOfCancerClassification,170.txt
excision/lumpectomy,147.txt
placed,92.txt
dataOn108Pb-dllPatientsFrom21ChineseMedicalCenters,93.txt
similar,142.txt
webOfSciencePsycinfo,200.txt
copyright,83.txt
search,31.txt
importantPhenotypicFeatureOfCdh1GermlineMutationCarriers,89.txt
keyCircadianClockGene,172.txt
haveClarified,131.txt
highlySensitiveNano-biosensor,235.txt
10Centers,72.txt
observed,93.txt
used,162.txt
Cells,128.txt
proteinKinaseC/extracellularSignal-regulatedKinasePathwayInSpinalCordInLumbarSegments4-6,46.txt
her2-positiveEarlyPatients,200.txt
characteristicsOfHighDimensions,170.txt
healthcareCost,22.txt
confirmed,238.txt
otherSites,107.txt
uncover,158.txt
researchLight,113.txt
95PercecntConfidenceIntervals,129.txt
thenUsed,170.txt
healthExpectancyOfItspopulation,145.txt
injury,227.txt
moreTargetedAdjuvantTreatments,241.txt
haveProposed,226.txt
identificationOfDistinctiveGeneticModificationsInDifferentBreastCancerMolecularSubtypes,225.txt
role,226.txt
richSpectralFeaturesOfPhenyboronicAcid-basedNanoprobe,234.txt
administered,197.txt
highestIncidenceAmongMalignanciesDiagnosedInWomen,127.txt
formedByCo-encapsulationOfNear-infraredFluorophoreInPegylatedMicelles,210.txt
5Percecnt,191.txt
completionOfReproductivePlans,193.txt
records,217.txt
univariateSensitivityAnalysesresults,69.txt
referenceForClinicians,100.txt
immunohistochemicalTests,102.txt
intopreGroups,146.txt
moreDirectional,144.txt
unusualPresentationOfSuperiorVenaCavaSyndrome,65.txt
used,1.txt
ourStudy,18.txt
patients,143.txt
managementOfTumour-relatedSymptoms,222.txt
manifold,59.txt
earlyStageDiagnosisOfTumors,9.txt
electricalDouble-layerCapacitors,176.txt
diagnosis,223.txt
rapidBreast-cancer-tissueDiagnosis,236.txt
nature,67.txt
registered,161.txt
twoCases,38.txt
involved,87.txt
relationship,233.txt
expressed,131.txt
exposed,200.txt
adultsWithHer-2PositiveBreastCancer,78.txt
consensus-based,188.txt
importantComponent,157.txt
twoSutegories,86.txt
asianPopulation,72.txt
expressionLevel,185.txt
validated,211.txt
singleMetastaticSite,4.txt
10NeedContents,23.txt
needed,92.txt
greaterthanorequalto1Lineage,191.txt
strategy,159.txt
91PercecntInPatientsWithBreastTumors,86.txt
7Percecnt,12.txt
target,197.txt
retrospectiveObservationalStudyOf264Her2-positiveAdvancedBreastCancer,4.txt
mayUsed,222.txt
significantAntiproliferativeActivityAgainstHumanTumorCellLines,181.txt
associationBetweenPost-diagnosisUseOfLow-doseAspirin,133.txt
significantlyDecreased,66.txt
evidence,201.txt
necessary,89.txt
inStudyDevelopedForHighlyEfficientIsolationOfCtcsFromBreastCancerPatients,178.txt
alsoShaped,138.txt
increaseWithNumberOfSprays,24.txt
up-regulated,70.txt
images,134.txt
canStressful,34.txt
case,6.txt
familyHistory,202.txt
factors,118.txt
diagnosis,111.txt
breastCancer,72.txt
resources,188.txt
patientsWithBreastCancer,238.txt
growthImplicatedInTumorigenesis,48.txt
study,160.txt
indicative,51.txt
lower,173.txt
dataForAccuracy,200.txt
potentialImpactOnFertilityAfterTreatment,230.txt
discoveryOfBiochemicalSignaturesMeasuredByMassSpectrometry,240.txt
defined,98.txt
couldDetected,188.txt
mostFrequentCancerInWomenTreatedWithHormonalTherapy,228.txt
use,207.txt
prognosis,187.txt
crucial,87.txt
currentlyUnclear,46.txt
discrete-timePartiallyObservableMarkovDecisionProcess,188.txt
conservativeTreatment,232.txt
conflict,231.txt
tamoxifen-resistanceInErCancerCells,189.txt
howeverStillUnclear,244.txt
riskFactor,118.txt
complexKaryotypes,191.txt
developmentOfBreastCancer,21.txt
foundInPcosCohortThanInComparisonCohort,117.txt
february2012InNargisDuttMemorialCancerHospital,108.txt
accurateDiagnosisInPediatricPatients,232.txt
mostCommonlyDue,166.txt
obtained,150.txt
13Percecnt,42.txt
moreInformationAboutFurtherStratificationOfBreastCancerSubtypes,225.txt
FPs,49.txt
over-represented,152.txt
enhancedPossibility,9.txt
NMA,237.txt
theirAdjacentMatchedTissues,172.txt
pituitaryFunction,57.txt
improvedDiagnostics,94.txt
especiallyModifiedOntoSurfaceOfNanoplatformForActiveHer2-targing,159.txt
constitutiveActivationOfDownstreamSignalingPathway,171.txt
89Years,217.txt
cellCycleArrestFollowedByMassiveCellDeath,128.txt
thirdInTermsOfSpecificMortality,79.txt
assessed,145.txt
benefit,93.txt
,96.txt
inception-v3Cnn,83.txt
Stem-likeCells,128.txt
value,169.txt
discussed,226.txt
needed,19.txt
breastCancerControlEfforts,40.txt
potentialImpact,230.txt
shown,46.txt
analyzed,47.txt
howeverSignificant,219.txt
anti-apoptoticEffectsOfEstradiol,21.txt
FIT,53.txt
845Percecnt,147.txt
asianCountries,72.txt
incompleteExcisionOfMalignantTissues,83.txt
negativeMargins,83.txt
disease,47.txt
priorities,92.txt
only35Cases,220.txt
comparedToThoseWithPregestationalBreastCancer,180.txt
randomEffectsModel,212.txt
majorObstacleInTreatmentOfTriple-negativeBreastCancerWithConventionalChemotherapeuticAgents,125.txt
treatment,126.txt
penalizedLogisticRegression,194.txt
heterogeneousCancerInFemalePatientsWorldwide,132.txt
cancer,225.txt
mainlyExpressed,206.txt
one-waySensitivityAnalyses,33.txt
images,144.txt
lungCancer,119.txt
riskOfBreastCancer,95.txt
higherRisks,145.txt
identified,134.txt
capacityForEarlyDiagnosisOfBreastCancer,53.txt
urgentlyNeeded,132.txt
6Months,163.txt
5CmLess,108.txt
otherSubtypesOfBreastCancer,28.txt
hazardRatiosWith95PercecntConfidenceIntervals,117.txt
necessary,220.txt
increasedRiskOfEndometrialCancer,117.txt
complexSemisolidMassesWithVaryingAmountsOfSolidComponents,43.txt
searched,75.txt
cancer,89.txt
women,243.txt
divided,163.txt
geneExpressionUpregulationInBreastCancer,58.txt
26/31,172.txt
subtype-specificPrognosticSignatures,218.txt
thenClassifiedBySupportVectorMachines,114.txt
obstacle,125.txt
accessToEarlyDiagnosis,187.txt
chestWallLesions,139.txt
patients,27.txt
projected,76.txt
issue,48.txt
growthOfCancerCellsInSkinOriginatingFromInternalCancer,215.txt
breastCancerGrading,59.txt
thanFamiliesOfPatientsWithNon-functioningPituitaryAdenomas,202.txt
studied,104.txt
initialTreatmentAfterWhich,17.txt
markers,51.txt
diet,227.txt
inadequate,239.txt
prognosisOfPatientsWithMaleBreastCancerInShanxiProvinceOfChinaFrom2007To2016,32.txt
localizedDisease,93.txt
pairedTumor,61.txt
costs,52.txt
frequent,23.txt
pregnancyOutcomes,180.txt
cxcSubtypeOfChemokineSuperfamily,48.txt
876Percecnt,147.txt
breastCancerWisconsin,175.txt
mostPrevalentMalignancyDiagnosedInPregnancy,231.txt
specificAreas,92.txt
issuesRelatedToTherapeuticSequencingInLocalTherapyOfBreastCancer,143.txt
malignancies,118.txt
amplifications,152.txt
growthHormoneReceptor,68.txt
scalable,22.txt
breastCancerIncidence,79.txt
willTested,79.txt
breastCancer,37.txt
oncogenesEsr1,58.txt
NLR,238.txt
choiceOfChemotherapyInBrca-associatedCancers,168.txt
risksOfLate-stageDiagnosis,145.txt
related,88.txt
imagingOfProstate,60.txt
relation,120.txt
resultOfPresentationWithAbnormalUterineBleeding,199.txt
canEasilyExtended,188.txt
aimed,131.txt
50,200.txt
termsOfMechanism,189.txt
affected,41.txt
globalHealth,165.txt
breastCancer,167.txt
form,173.txt
breastCancerBrainMetastases,73.txt
roleOfAutoantibodiesInEarlyCancerDiagnosis,44.txt
growth,48.txt
typicalWoman'sDisease,177.txt
covariates,183.txt
identifiedAsMostEffectiveMolecules,209.txt
noninvasiveImagingTechniqueForBreastCancerDiagnosis,116.txt
bilateral,43.txt
resistance,198.txt
genesCodingForTumorSuppressorProteins,98.txt
infiltrativeLesion,121.txt
mostFrequentMetastaticTumors,199.txt
test,207.txt
reportedInSignificantlyHigherProportionOfPatientsWithPa,202.txt
shown,246.txt
protectiveRoleOfRs5743810,13.txt
downregulated,77.txt
effectivenessOfDifferentNpatsOnQolInPatientsWithBreastCancer,237.txt
differentiationBetweenBreastCancerInVariousSubtypesOfBreastCancer,150.txt
clinicopathologicalFeaturesOfT-mnPatients,191.txt
patientsWithLocoregionalInSouthernPortuguese,1.txt
important,175.txt
triple-negativeSubtypeMda-mb-231Cells,205.txt
.021,196.txt
C1,120.txt
haveConducted,226.txt
increase,16.txt
inStudyDevelopedByCell-selex,55.txt
breastCancerCells,159.txt
moreEffectiveTreatmentOfLungCancers,9.txt
betterAccessToAtertiaryCancerCenter,145.txt
insufficient,190.txt
dnaDamage,135.txt
theirRisk,158.txt
tamoxifen,97.txt
sexualDysfunction,151.txt
femalePatientsWithAd,66.txt
subsequentPrimaries,118.txt
found,85.txt
unclear,61.txt
roleOfCircularRnas,137.txt
uncouplingOfInverseCorrelationBetweenBmi,174.txt
cytotoxic,191.txt
canDetected,137.txt
frequentInformationalNeeds,23.txt
lowIncidence,164.txt
routineUseByFoodAdministrationIn2002,217.txt
colorectalTissue,206.txt
familialCancerClusteringInPatientsWithProlactinoma,202.txt
quantification,176.txt
agents,142.txt
MRI,216.txt
dnaMethylationDifferencesBetweenTumorBreastTissue,58.txt
detectionRateOfMutationsHigherThanThatDescribedInLiterature,241.txt
small,235.txt
investigated,130.txt
non-nsaidUsers,66.txt
pro-tumorigenicMicroenvironment,84.txt
highlightConsiderations,75.txt
made,187.txt
multivariateModelsAdjustedForIncome,187.txt
switched,6.txt
mostToxic,173.txt
documentationOfPatientAge,217.txt
methods,7.txt
currentUsersOfLongerDuration,208.txt
currentResults,169.txt
compared,44.txt
cancerType,160.txt
activatedComplex,189.txt
PM,228.txt
lentivirusTransduction,172.txt
freshLeafEthanolicExtract-treatedMda-mb-231Cells,173.txt
diverse,128.txt
40Percecnt,191.txt
244GermlineVariants,110.txt
proposedTotal-variationSchemeWithSpatially-varyingAnisotropicWeightingCompensateForGeometricBiasFromLimitedAngleImagingSetup,36.txt
Chi,61.txt
clinicalSettingOfPreviouslyVagueDiagnosisInImaging,10.txt
pediatricPopulation,232.txt
biologicallyDifferentDiseaseInWomen,119.txt
levelsOfEralphaProtein,70.txt
developed,1.txt
significance,235.txt
limited,179.txt
t-MN,191.txt
context,129.txt
expressionOfItsTargetProteinCytokine-inducedApoptosisInhibitor1,125.txt
protected,135.txt
identified,6.txt
pre-diagnosticObesity,146.txt
womenWorldwide,237.txt
usd$901,69.txt
factor,190.txt
promisingBiomarkers,206.txt
radiation,37.txt
hasMade,55.txt
made,176.txt
moodOfLife,151.txt
howeverElusive,105.txt
updateOnRiskFactorsForSeromaProductionAfterBreastCancerSurgery,203.txt
chemotherapy,6.txt
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab,142.txt
asResultAreUsed,210.txt
subsequentMalignanciesForLung/bronchusCancerWith13PercecntSurvivorsSufferedFromSubsequentMalignancies,118.txt
importantAspect,23.txt
canHeavilyInfluenced,64.txt
mostCommonMalignantTumor,100.txt
chemotherapyResistance,151.txt
used,143.txt
brca1Levels,135.txt
differentPatientRaces,236.txt
annualMammographyAssociatedWithEchography,80.txt
analyzed,81.txt
g1/s-phaseCellCycleArrest,82.txt
betterPrognosisInBl1Patients,106.txt
maintenanceOfErCancerStemCells,189.txt
thenShouldTestedForSpecificGeneMutationFound,98.txt
haveAllProposedAmongPotentialPathways,43.txt
womenAcrossGlobe,49.txt
cancer-relateddeaths,39.txt
related,118.txt
determined,235.txt
clinicalSecondLevelExamination,50.txt
canines,44.txt
satisfied,92.txt
rangingFromDiagnosisPhaseToControlOfDisease,35.txt
negative,123.txt
specificMethylationMarkersImportantForCrcDetection,226.txt
highlyEffective,128.txt
correlated,163.txt
hasUsed,101.txt
enrolled,66.txt
her2Status,167.txt
phosphorylationOfAkt,229.txt
assay,44.txt
crucial,189.txt
termsOfClassification,113.txt
fibrosis,217.txt
realStatusOfPrs,72.txt
thatOfOtherCountries,32.txt
commonPlatformForStakeholdersIncludingPolicymakers,157.txt
compared,246.txt
cancerCounseling,118.txt
need,14.txt
able,50.txt
dependent,167.txt
depicted,137.txt
therapeuticBenefits,139.txt
youngAge,103.txt
analyzed,179.txt
cardiotoxicRisk,27.txt
significantConnection,68.txt
RNAs,137.txt
reducedBaselineLvef,27.txt
intravoxelIncoherentMotionParameters,150.txt
fewerInstancesOfSpreadToLungs,152.txt
third,79.txt
assessments,22.txt
tumor-bearingMiceOfMcf-7BreastCancerCells,55.txt
thoughtfulMultidisciplinaryPlanning,143.txt
opportunitiesForResearchInBreastSurgery,92.txt
differentFunctionRegions,58.txt
positive,97.txt
protected,83.txt
roleOfImage-basedTextureFeaturesAsNoninvasivePrognosticBiomarkers,11.txt
itsDiagnosticPerformance,194.txt
27PerCentOfPatients,217.txt
prognosticSignificanceOfNlrInEarlyStage,238.txt
common,57.txt
uniqueFeatureInteractWithNucleicAcids,137.txt
imagingInvestigations,220.txt
erCscs,189.txt
correspondingHistologyImage,83.txt
inColorectalCancersHaveConducted,226.txt
57PercecntOfPatients,110.txt
risk,202.txt
polymorphism,95.txt
youngWomen,193.txt
commonFeature,156.txt
allow,51.txt
group-basedTrajectoryModelling,183.txt
performance,83.txt
modelAccount,63.txt
510YearsAfterSurgery,26.txt
observed,104.txt
ASSIA,75.txt
autosomal-dominantlyInheritedCancerSyndromeAssociatedWithRiskCausedByHeterozygousCdh1GermlineMutations,89.txt
patientsWithCancer,164.txt
rare,216.txt
modelling,183.txt
definitionOfHealthLiteracy,75.txt
function,27.txt
detectionOfBreastCancerInWomen,144.txt
stillDifficult,100.txt
status,72.txt
hidden,74.txt
non-smallCellLungCancer,51.txt
found,58.txt
them,199.txt
molecular,171.txt
mutationalStatusBesidesFamilyHistory,141.txt
inPresentStudyPerformedFor9Features,175.txt
whereFormulated,36.txt
concentrationsOfVegf-aInComparisonToCa15-3InBreastCancer,16.txt
mda-mb-231CellsMeasuredBy3,173.txt
upregulated,131.txt
howeverKnown,99.txt
associated,56.txt
weak,151.txt
earlyDiagnosisOfCancerPatients,206.txt
mostInvolvedSegmentsWithSuvmax39,104.txt
managedWithPalliativeRightHemicolectomyInViewOfConstipationAsSystemicTreatment,215.txt
women'sCancerAccounting,80.txt
mostFrequentCause,166.txt
population-basedStudies,21.txt
resistanceToExistingTherapies,201.txt
association,13.txt
fiveDoses,139.txt
uniqueProperties,21.txt
non-smallCellLungCancer,172.txt
fused,154.txt
proposedForBreastTumorGrading,59.txt
evidencedByIncreaseInContrastAfterInjection,210.txt
images,50.txt
hoechstStaining,244.txt
criticalScientificBaseForPrecisionMedicineInBreastCancer,225.txt
arms,19.txt
continuousDynamicCyclesOfFission,77.txt
quality,237.txt
successfulFunctionalizationOfNanocompositeOfSpecificSequenceOfAminatedComplementaryOligonucleotideOfMirna-21,235.txt
cnvsOfDifferentCancers,192.txt
involvedInDnaDamageRegulation,135.txt
malign,144.txt
dominantArms,19.txt
cross-sectionalCategories,35.txt
risk,158.txt
stained,173.txt
algorithm,20.txt
identified,152.txt
pretermBirth,180.txt
inHumanBreastCancerHasReported,18.txt
advancedTechnologies,122.txt
novel,85.txt
canClassified,40.txt
strongContrastWithImagingModalities,210.txt
imaging,210.txt
89FfdmCases,101.txt
cancer-relatedDeathInChineseWomen,221.txt
moreoverMostOfTimeBenignRequired,34.txt
histopathologicalDiagnostics,12.txt
2/149,217.txt
expressionInBreastCancer,61.txt
analysis,32.txt
cytotoxicActivitiesOnMcf7,244.txt
practitionerDecisionmaking,40.txt
goodDiagnosticAbility,184.txt
evenNeeded,71.txt
opticalCoherenceTomographyImages,83.txt
henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer,207.txt
therebyFrequentlyNeglected,231.txt
shouldPerformed,80.txt
diagnosis,226.txt
prevention,21.txt
case,122.txt
lymphNodeMetastasisInPatientsWithBreastCancer,131.txt
32620MatchedPatientsWithoutPcos,117.txt
care,22.txt
pitfall,104.txt
critical,48.txt
correlationCoefficientOnMetabricTrainingSet,192.txt
terms,57.txt
correlativeEntities,95.txt
history,166.txt
positivelyCorrelated,163.txt
phosphoinositide3-kinase,171.txt
complex,180.txt
associated,168.txt
differentHistologicalAspects,120.txt
neglected,231.txt
diagnosisOfPatientsWithBreastCancer,167.txt
performed,98.txt
substantialDiscordancesBetweenPrimaryTumors,241.txt
sensitivityOfDrug-resistantCellsToChemotherapeutics,125.txt
colon,215.txt
profile,233.txt
pax6GeneExpression,41.txt
kaplan-meierRegressionMethods,187.txt
transcriptionalActivityOfHypoxia-inducibleFactor1,156.txt
women,47.txt
focalNeurologicDeficit,76.txt
mostCommonCancer,87.txt
retrospectiveStudyOfWomenTreatedWithTrastuzumabForHumanEpidermalGrowthFactorReceptor2BreastCancerAtMayoClinicBetweenJanuary12000,27.txt
0.029,169.txt
anastrozole,67.txt
experimentalStudyOfCryo-stabilityOfCancerCells,8.txt
number,53.txt
Europe,94.txt
ssessed,41.txt
bone,72.txt
canCategorized,192.txt
positiveRegulatoryFeedbackLoopForFxyd3Amplification,189.txt
mostOfPatientsDuringMammography,31.txt
result,121.txt
hematologicalMalignancy,191.txt
Japanese,110.txt
FFDM,101.txt
understanding,21.txt
modeled,188.txt
dissection,19.txt
incision,122.txt
complementaryBenefit,93.txt
featured,106.txt
differentContrastAgent,210.txt
segments,104.txt
histopathologicallyProvedBreastTumors,184.txt
womenWithExtremelyDenseBreasts,148.txt
analyzed,120.txt
usedAtOurInstitutionForSelectPatientsWithGoodOutcomes,217.txt
selectiveAccumulationOfFluorescentOsteopontinInVitroAndInVivo,134.txt
positive,178.txt
significantlyHigherThanInFamiliesOfNfpaPatients,202.txt
essential,12.txt
excellentPerformanceInFieldOfMedicalImagesDiagnosis,83.txt
initiationOfBreastMalignancy,42.txt
world,100.txt
5Μl,176.txt
haveAssociatedWithNippleAreolaComplexInvolvementInPatientsWithBreastCancer,109.txt
important,230.txt
mostInvasiveDisease,144.txt
study,35.txt
examined,194.txt
possibleCorrelationsWithClinicalStatusIncludingAge,246.txt
23Studies,142.txt
appearance,90.txt
associationBetweenPost-diagnosisLow-doseAspirinUse,133.txt
place,143.txt
warfarin,160.txt
faSignalingNetwork,213.txt
novelStrategiesForDiagnosisOfBreastCancerWithHyperglycemia,229.txt
etiologyOfManyDiseases,95.txt
shouldTested,98.txt
dual-energyAcquisition,34.txt
proposedHowever,36.txt
mostlyBilateral,43.txt
appropriateIntegrationOfPreprocessing,49.txt
least,51.txt
bortezomib,46.txt
expressionLevelsOfProteinsAssociatedWithEpithelial-mesenchymalTransition,130.txt
redoxStatus,173.txt
hasDescribedInFewHdgcFamilies,89.txt
indicationsForRisk-reducingSurgery,92.txt
roles,40.txt
breastCancerPatientsSerum,132.txt
associated,131.txt
analysisOfLncrnaExpressionProfiles,190.txt
events,196.txt
clinicalDiagnosticPathways,51.txt
hasAlreadyAssociatedWithDifferentCancersNon-hodgkin'sLymphoma,97.txt
obtained,133.txt
mir-511Expression,131.txt
advancesInBreastCancerDiagnosis,195.txt
90PercecntOfPatients,191.txt
putativeBiomarkerForDetectionOfVariousHumanDiseases,137.txt
amenorrhea,96.txt
only20Percecnt,100.txt
specificSubtype,102.txt
review,72.txt
addition,221.txt
urgentlyAdvanceImplementation,157.txt
moreResearchLight,113.txt
ourFacility,147.txt
mostPrevalentMalignancyAmongWomenAroundWorldAreDiagnosedYear,154.txt
OS,102.txt
attentionToSpecialGroups,92.txt
accuracy,101.txt
canDetectedInBodyFluidsIncludingSerum/plasmaSamples,226.txt
serumSamplesFromCancerPatients,176.txt
93Percecnt,27.txt
promising,148.txt
challenge,31.txt
linked,24.txt
necessity,220.txt
largestReviewOnPrsInAsianPopulation,72.txt
inexpensiveTechnique,52.txt
cause,101.txt
importance,7.txt
preclinicalModels,128.txt
management,22.txt
breastCancer,20.txt
cancer,14.txt
potentAnticancerActivity,244.txt
2007,112.txt
potentialSourcesOfVariance,74.txt
well-established,176.txt
prominentSourceOfCancerMortalityInWomenThroughoutWorld,244.txt
preparedRespectively,173.txt
effectOfSex,164.txt
unknown,229.txt
expressedSeparately,44.txt
glycosylation,132.txt
greatClinicalImpactForTumorDiagnosis,178.txt
assessed,2.txt
malignancy,154.txt
inBreastTumorsKnownAsBreastCscs,195.txt
whenPerformedBeforeMenopause,98.txt
directlyAffectedByOverexpressionDownRegulationOfManyMirnas,71.txt
levels,244.txt
therapeuticallyEffective,46.txt
scEnrichment,156.txt
copyright,93.txt
ronInternalization,128.txt
clinicalCare,157.txt
fourTypesOfBreastCancer,132.txt
clinicalApplicabilityOfOurMethodInBreastCancerImagingSetting,36.txt
breastCancerTreatment,198.txt
inborn-likeErrorsOfMetabolism,240.txt
uncommon,10.txt
syndromes,94.txt
usualCare,22.txt
62Years,32.txt
used,211.txt
times,151.txt
IMR,115.txt
tested,165.txt
clarify,102.txt
breastCancerProgression,221.txt
fluorescenceMicroscopy,173.txt
henceMajorResearchGoal,223.txt
survivalOfCellsInVitroAndInVivo,77.txt
cytokineFunctionsLeadingToDevelopmentOfCancers,84.txt
conflictBetweenCareOfMother,231.txt
adverseEffectsOfMtorInhibitors,104.txt
dealingWithEndocrineResistanceInPatientsWithBreastCancer,70.txt
leadingCancerSitesInOlderMales,161.txt
characteristicsInsideTumors,184.txt
directActingOralAnticoagulants,160.txt
PA,202.txt
significantlyAssociated,131.txt
phosphatase,85.txt
osteopontinPeptide,134.txt
involvementOfPtenInCs,85.txt
patientsWithReducedBaselineLvef,27.txt
mightMetastaticCrcMarkers,206.txt
crucial,19.txt
survivalTime,130.txt
used,2.txt
three6-monthPeriods,2.txt
,201.txt
outpatientClinic,202.txt
modified,174.txt
evenSeveralChemotherapySessions,197.txt
literatureForFamiliesWithCdh1Mutations,89.txt
potentialForOverdiagnosis,115.txt
importantComponentOfMitoticCheckpointMachineryHaveShownInSeveralCancersIncludingAnaplasticThyroidCancer,221.txt
couldPotentialBiomarker,13.txt
recommended,4.txt
conditions,137.txt
bone-modulatingAgents,121.txt
risk,22.txt
solidTumors,121.txt
highPercentageOfRemissionMaintenance,57.txt
use,174.txt
qualitativeApproach,35.txt
145Percecnt,72.txt
foxc1-knockdownBt549Cells,105.txt
heterogeneousPopulationsOfCellsWithHierarchicalOrganizationDrivenByCancerStemCells,195.txt
identified,154.txt
average,152.txt
adjustedHazardRatio,66.txt
developmentOfEffectiveDrugsForTreatmentOfHormone-dependentBreastCancer,42.txt
inBelgiumMostFrequentWomen'sCancerAccountingForTo353PercecntOfCases,80.txt
found,104.txt
complex,157.txt
relationshipBetweenStromalExpressionOfPodoplaninInInvasiveBreastCarcinoma,233.txt
triple-negativeBreastCancers,87.txt
used,114.txt
visits,188.txt
multipleBiological,192.txt
hasObserved,137.txt
differentiation,39.txt
including,190.txt
presentation,65.txt
developmentOfGraphicallyTailoredScreeningTool,1.txt
downregulated,185.txt
BRCA1,141.txt
v-gCalciumChannelBindingAntibodies,67.txt
applied,19.txt
workflowConsistingOfImmunoaffinityPurification,154.txt
subsequentLung/bronchusMalignancies,118.txt
knowledgeOfM,32.txt
breastCancerCells,18.txt
moreAdvancedStagingAtDiagnosisInWomen,187.txt
gynaecologicalMetastases,152.txt
boundErythematousAppearance,90.txt
medianFollow-upOf48Years,133.txt
compared,196.txt
adenocarcinomaFeatures,215.txt
haveReported,220.txt
breastCancer,123.txt
novelInsightsIntoPotentialMechanismsAssociatedWithBreastCancerPathogenesis,81.txt
fiveDosesOfAdjuvantTranstuzumab,139.txt
moreRecentlyHaveDeveloped,136.txt
associationsBetweenChangeOfPerceivedWorkAbility,2.txt
number,170.txt
promisingNoninvasiveBiomarkerForDetectionOfDiseases,137.txt
survivalPrediction,190.txt
paper,205.txt
similar,163.txt
lessEffective,148.txt
family,137.txt
modulated,84.txt
oftenDebated,79.txt
canEffectivelyTreatedByEndocrineTherapy,70.txt
prohibitivelyExpensive,33.txt
association,219.txt
whenonlyAnalyzed,146.txt
240MonthsWith1SurvivalRateOf707PercecntRespectively,119.txt
mainlyObserved,104.txt
oncology,76.txt
effectOnBoneRemodelingThroughItsReceptor,95.txt
developmentOfMetabolicDisorders,95.txt
cellMigration,41.txt
identified,200.txt
screened,154.txt
feature,89.txt
malformation,73.txt
comparisonToCa15-3,16.txt
longPeriodOfTime,57.txt
perturbation,116.txt
throughOptimizationTestsChosenAsOptimalConditions,178.txt
differentiallyExpressedInBreastCancerCells,81.txt
shouldGivenToGeriatricOncology,161.txt
howeverMaySometimesDifficult,149.txt
bindingToBreastCancerCellsInVitro,134.txt
controversial,66.txt
typicalHormone-dependentTumor,26.txt
minimalRisksToNormalCells,9.txt
subtyped,236.txt
correlated,189.txt
bioinformaticAnalysis,41.txt
mostPrevalentCancer,49.txt
analysis,1.txt
threeDifferentUsMachines,194.txt
inhibitionOfCellProliferation,106.txt
changes,129.txt
shouldPerformed,31.txt
importantContributors,225.txt
cancerPatients,160.txt
concernForExistenceOfCancerCellsInGrafts,8.txt
conducted,200.txt
0.32,129.txt
evolve,143.txt
diagnosisOfCancer,186.txt
protectiveFactors,118.txt
diagnosis,60.txt
conducted,217.txt
medicalDiagnosisOfBreastCancer,7.txt
soFarHasMainlyAssociatedWithMutationsInBrca1,141.txt
worseOutcome,102.txt
world,175.txt
role,199.txt
childbearingReasonsIncluding,193.txt
inclusionCriteria,200.txt
recognizedAsCtcIn1Of15HealthyBloodSamples,178.txt
women,193.txt
estrogen-aloneArmOfWhi,21.txt
multiyearCollaborationLedByUnionForInternationalCancerControl,157.txt
shaped,138.txt
included,102.txt
TIVAP,164.txt
treatment,218.txt
mortalityRates,81.txt
analysisInvestigate,24.txt
treatmentWithWholeBrainRadiotherapy,73.txt
inherited,89.txt
prevalenceOfobesityOf277Percecnt,146.txt
differentiation,150.txt
resistantToExonuclease-mediatedDegradation,137.txt
skullLesions,166.txt
important,69.txt
treatmentOfHormoneReceptor-positiveBreastCancer,199.txt
choreiformMovements,67.txt
773Percecnt,4.txt
doseConcerns,50.txt
identified,147.txt
abstractDataOnTheirClinicalCharacteristics,108.txt
howeverSwitched,6.txt
10Percecnt,147.txt
youngerBreastCancerSurvivors,165.txt
defectStudies,7.txt
variousEnvironments,114.txt
needForNodalRadiotherapyInSpecificSituations,143.txt
panelOfCellLinesWithDifferentPhenotypes,128.txt
molecularDiagnosisMethodMake,234.txt
extensiveMolecular,127.txt
improved,157.txt
magneticResonanceImaging,184.txt
statusOfScreeningWomenWithDenseBreasts,148.txt
accuracyOfLesionDetection,60.txt
potentialImportanceAsModelsForHumanBreastCancer,44.txt
shouldAdministered,25.txt
anti-oncogenicRegulationOfMir-34s,3.txt
focal,31.txt
patientsWithNeoplasticDisease,111.txt
cardiacInjury,227.txt
decreasedRiskOfBreastCancerInFemaleAdPatients,66.txt
68Percecnt,47.txt
localizedDescriptionOfBreastCancer,11.txt
used,8.txt
timeOfTheirAppointmentwithDoctor,47.txt
veryComplexDisease,218.txt
motivated,84.txt
vitalRoles,40.txt
theyCanImpactOnQualityOfLifePresent,230.txt
appropriateDiagnosisOfBreastCancer,225.txt
common,192.txt
largeNumberOfTumor-freeData,170.txt
fiveGroups,111.txt
massSpectrometry,132.txt
lesion,166.txt
january1998June2017,219.txt
higher,163.txt
posteriorFossaOfBrain,10.txt
alsoUsed,7.txt
tests,91.txt
invasiveCarcinomaBreast,109.txt
AUC,44.txt
0.0001,4.txt
earlyDetectionOfProstateCancer,226.txt
associated,159.txt
unknown,160.txt
breastCancer,150.txt
addition,199.txt
factors,186.txt
useful,151.txt
acceptableSafetyMargins,31.txt
inContextAppliedInClinicalDiagnosticsInClinicalTrialsForPurposeOfStratification,74.txt
furthermoreEnhanced,130.txt
significantlyYounger,152.txt
evaluated,118.txt
barrierFunction,37.txt
effect,219.txt
invasive,57.txt
otherTwoGroups,162.txt
pathogenicVariantsInBrca1/2,110.txt
percentageChangeInIncidenceRates,115.txt
breastCancer,35.txt
methylationStatusOfPcdh10InBreastCancerTissues,185.txt
positive,6.txt
averageOfFiveInvolvedSites,152.txt
issues,230.txt
january1990,75.txt
patientsWithMeasurementErrors,116.txt
mightUseful,86.txt
neutralEffects,13.txt
panelOfMonoclonalAntibodiesAgainstNewlyEstablishedCellLine,154.txt
recruitmentOfOlderAdults,201.txt
hasMadeInMolecularSubtypingOfBreastCancer,55.txt
biopsy,175.txt
observation,89.txt
inConclusionPathogenicFeatureInPrimarySamples,128.txt
138Patients,191.txt
youngWomenWithInvasiveLobularCarcinoma,152.txt
highestSeInTotalGroup,16.txt
factors,72.txt
usuallyMacroadenomas,57.txt
healthyWaysOfLife,186.txt
related,4.txt
observed,137.txt
uptake,9.txt
givenRecentConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis,207.txt
observed,197.txt
cells,239.txt
potentAnticancerEffects,140.txt
news,64.txt
increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings,208.txt
differentGeneticProfile,233.txt
lower,116.txt
associationWithImagingOfIgm,31.txt
complex,218.txt
effectOfBaicalinInBreastCancer,82.txt
role,243.txt
haveReportedMainlyAfterMastectomy,220.txt
7051UnselectedBreastCancerPatientsOfJapaneseAncestry,110.txt
reported,202.txt
increasedRisk,158.txt
99PercecntAccuracyInTermsOfClassification,113.txt
role,137.txt
whenActiveUse,174.txt
-69PercecntTo+239Percecnt,115.txt
rocCurveAnalysis,86.txt
nano-biosensor,235.txt
desirable,178.txt
present,222.txt
computedTomography,215.txt
thusImportant,69.txt
clinico-pathologicalFeaturesOfMetastases,152.txt
assessedAtBaseline,2.txt
performed,212.txt
effectsOfTreatment,80.txt
conclusion,130.txt
unitedKingdom,115.txt
ai-associatedSevereTendinopathy,216.txt
results,133.txt
tamoxifenResistance,70.txt
case,197.txt
clinicalBreastExaminationCoupledAsPrimaryTool,33.txt
sixGlycosylationSites,132.txt
system,224.txt
study,4.txt
extensiveAttentionOfResearchers,42.txt
identified,132.txt
mostSensitiveTestForBreastCancerDetection,207.txt
risingTrendOfColorectalCancers,53.txt
potentialBiomarker,106.txt
associationsBetweenAspectsOfDiet,186.txt
mir-193b-3pBindingTo3UntranslatedRegionOfMorc4,81.txt
tumorGrowth,131.txt
invasiveBreastCarcinoma,233.txt
danger,231.txt
standardOfCareAsFirst-lineTreatmentOfPatientsWithHer2-positiveAEvenInReal-worldSetting,4.txt
differentClinicalOutcomes,149.txt
capecitabineRegimenAsThird-lineTreatmentForAdvancedTriple-negativeBreastCancer,196.txt
haveUsed,20.txt
used,183.txt
treatment,139.txt
whereNeeded,166.txt
predictive,200.txt
0.003,4.txt
compared,86.txt
bortezomib-inducedColdAllodynia,46.txt
whole-tumorSamplingOfDiseaseBurden,11.txt
whereDeveloped,101.txt
generallyReserved,222.txt
,120.txt
neuralNetworkClassifier,144.txt
couldEmployed,159.txt
bl1CellMda-mb-468,106.txt
intralaboratoryValidationSet,236.txt
worldwide,114.txt
mostCommonUltrasonographicFindings,31.txt
detection,59.txt
neuropathy,46.txt
itParticularlyAttractiveAsPotentialAgentInBreastCancerPrevention,219.txt
offered,91.txt
used,132.txt
canIncluded,30.txt
mayIndicativeOfBenignLesion,220.txt
canineTumours,44.txt
initialPresentationOfInvasiveBreastCancer,121.txt
elusive,240.txt
classified,129.txt
independentPrognosticFactorForDfsOfEarlyStageBreastCancer,238.txt
576Percecnt,119.txt
normalCardiacFunction,27.txt
byMultivariateAnalysisSignificantIndependentPrognosticFactorOfOs,86.txt
infraredFluorescentDye,134.txt
theirInteractions,68.txt
18.791,32.txt
finalAssessment,34.txt
alcoholConsumption,129.txt
alreadyWell-established,176.txt
totalHemoglobinConcentration,116.txt
conducted,109.txt
mir-193b-3pIdentifiedAsRegulator,81.txt
HR,236.txt
highlyExpressed,221.txt
clinicalVariablesAmongDifferentGroups,103.txt
energyImage,101.txt
hasFocused,233.txt
copyright,33.txt
YS,214.txt
higherProportion,163.txt
drawbacks,7.txt
notablyUpregulatedWithinPatients,137.txt
duringAgeAssociatedWithIncreaseOf8MoreFemaleBreastCancerCasesPer100000DuringAge50-54,24.txt
importantCopingResource,214.txt
carcinoma,73.txt
characterizedByAcuteAppearanceWithErythematousPlaqueSometimesHotMoreOftenSituatedInPrimaryTumorVicinity,90.txt
study,156.txt
improvedQualityOfLife,151.txt
itSideEffects,76.txt
target,42.txt
consensus,24.txt
imbalanceInCytokineProfilesInPro-tumorigenicMicroenvironment,84.txt
earlyBreastCancer,124.txt
commonlyUsedAntihormonalTherapyInTreatmentOfBreastCancerInPostmenopausalWomenSpecificallyInTreatmentOfHormoneReceptor-positiveBreastCancer,216.txt
failure,25.txt
inflammatory,31.txt
NSCLC,172.txt
breastCancer,82.txt
diagnosis,149.txt
routine,124.txt
brd4Regulation,135.txt
breastCancerTissueMicroarrayWithAccessToReceptorAnalyses,245.txt
MSOT,134.txt
analyzed,146.txt
recruitment,201.txt
therapeuticTargetForPotentialTreatment,128.txt
her-2PositiveBreastCancer,78.txt
ages,98.txt
recentYears,231.txt
consensusOnAssociationBetweenExposureToDdt,24.txt
differentiallyModulated,84.txt
28Segments,104.txt
evenMorePersonalizedFollow-upSchedules,188.txt
proliferationOfThreeCancerCellLinesWithLowIc,209.txt
highBurdenOfCancer,53.txt
73-yearOldWomanPresentingWithLeftBreastLumpClinicallyIndeterminate,107.txt
worldwideHighestAge-standardizedBreastCancerIncidence,79.txt
features,39.txt
life-threatening,168.txt
breastTumorigenesis,71.txt
clinicalBreastExamination,53.txt
found,119.txt
pb-ctMode,224.txt
howeverShouldPerformed,31.txt
diagnosticValueOfMarkers,12.txt
surrogates,239.txt
used,82.txt
effective,22.txt
useful,58.txt
patients,119.txt
status,148.txt
evaluation,74.txt
oncogene,106.txt
cancers,226.txt
sideEffectsOfBreastCancerTherapiesIncludingHotFlushes,151.txt
effectiveDiagnosisOfBreastCancer,218.txt
treatment,193.txt
now89Years,217.txt
couldIndependentPrognosticBiomarkerForMPatients'Outcomes,169.txt
anotherOfSeveralIndividualsInOneFamilyAffectedByCs,85.txt
244GermlinePathogenicVariants,110.txt
643PercecntWithSignificantDifferenceBetweenWhites,187.txt
cervicalCancer,130.txt
needed,202.txt
pathologistAnnotation,37.txt
canClassified,51.txt
cancer,87.txt
centralRoleInBreastCancerResearch,92.txt
shouldCo-managedByCardiologist,27.txt
abnormalUterineBleeding,199.txt
commonMedications,66.txt
menopause,57.txt
environmentalFactors,186.txt
time,215.txt
geneticPredispositionForCancer,94.txt
termsOfProlactinNormalizationInPituitaryFunction,57.txt
notablyDesigned,218.txt
GTPase,18.txt
based,147.txt
quality,228.txt
survival,76.txt
1H,176.txt
needsInPrevention,177.txt
bareCapillaries,176.txt
significantlyUp-regulated,189.txt
familyHistoryOfDisease,158.txt
advantage,44.txt
terms,71.txt
lymphedemaPatients,151.txt
464Percecnt,108.txt
targeted,159.txt
revisionsOfAjccBreastCancerStagingSystem,167.txt
pathogenic,128.txt
cnvData,192.txt
typeOfCollisionTumor,10.txt
hereditaryCausesOfChorea,67.txt
breastCancer,55.txt
detected,61.txt
assessed,169.txt
elusive,105.txt
evaluated,31.txt
ukCancerIncidence,115.txt
tool,113.txt
shouldEstablished,53.txt
rare,177.txt
migrationAbilitiesOfCervicalCancerCells,130.txt
tataMemorialCancerHospital,49.txt
estimated,7.txt
cancerTreatment,241.txt
atrophiedVaginalMucosa,151.txt
used,170.txt
shouldEstablishedBetweenScreeningWithImplementationOfRobustQualityAssurance,53.txt
breastCancerMcf-7,82.txt
expected,23.txt
improvedPatientOutcomes,140.txt
proteinExpressionOfNf-krab-p65,82.txt
cellInvasion,105.txt
twoCases,17.txt
cancer-relatedEventsIncludingTumorCellMigration,246.txt
reported,97.txt
environmentalFactors,89.txt
used,163.txt
mostCommonCancer,157.txt
pi3k-akt-mediatedMitochondrialSignalingPathwayTumorSuppressorMir-10a,244.txt
breastSurgery,92.txt
markedlyUp-regulated,70.txt
30DoublingTimesNecessary,21.txt
chemotherapy,237.txt
important,166.txt
known,99.txt
diverseBiologicalProcesses,18.txt
outcomeOverCosts,207.txt
panel,241.txt
cancer,157.txt
inclusionCriteria,75.txt
additionallyRevealed,131.txt
mortalityRates,115.txt
fieldOfBreastCancerDetection,64.txt
dissectionOfLymphNodes,19.txt
baicalin,82.txt
used,44.txt
developmentOfClinicalDecisionSupportSystemsForBreastCancerDiagnosis,62.txt
mechanism,77.txt
haveProposed,43.txt
important,199.txt
ductalCarcinoma,126.txt
numberOfLong-termSurvivors,72.txt
mildUvLight,211.txt
tumorigenesisOfBreastCancer,131.txt
high-riskWomen,148.txt
only1ulOfSerumSample,44.txt
correlated,206.txt
thusAimed,131.txt
417Percecnt,197.txt
definiteDiagnosisParticularlyInSmallBiopsies,149.txt
designedByDivisionForBreastCancerOfKoreanRadiationOncologyGroup,126.txt
AD,66.txt
associated,45.txt
importantIntercellularSignalingRegulatorWithExpressionCorrelation,211.txt
indicator,141.txt
dependentOnRigorousPathologicEvaluationOnAdministrationOfTreatmentDictatedByTumorBiology,167.txt
percecntRelapsedTissues,241.txt
investigate,200.txt
oestrogenReceptorPositiveIn58PercecntOfCasesPositiveIn62Percecnt,147.txt
mastectomies,67.txt
common,161.txt
futureDirections,183.txt
cytotoxicity,205.txt
mass,10.txt
predominant,66.txt
713Percecnt,200.txt
shouldProcessed,40.txt
willDifferent,80.txt
leftParietalRegion,97.txt
assessedinclusionCriteriaForEnrolment,147.txt
effect,46.txt
CIAPIN1,125.txt
challenge,196.txt
application,50.txt
otherImagingCharacteristics,43.txt
chorea,67.txt
mostCommonExtrinsicCause,65.txt
earlyBiomarkersOfBreastCancerRisk,174.txt
others,95.txt
brca-associatedCancers,168.txt
mightPromisingTherapeuticStrategyForHormone-therapyRefractoryEr,189.txt
mostFrequentMalignancy,1.txt
questionnaireAdministeredOnJapan'sLargestCancerInformationWebsite,23.txt
womenOfAverageRiskWithDenseBreasts,148.txt
progression-freeSurvival,168.txt
uterus,199.txt
mostPervasiveTypeOfCancerAmongWomen,59.txt
mayUsedForTumourShrinkagePriorToSurgery,222.txt
collection,65.txt
veryRareCaseOfTraumaticBreastNeuroma,220.txt
kaplanMeierCurves,4.txt
has-miR-3158-3p,68.txt
administrationOfNeoadjuvant,102.txt
moreRecommended,10.txt
threeKinds,170.txt
disease,177.txt
study,39.txt
alsoObserved,226.txt
aspect,23.txt
nsclcPatientsAssociatedWithShorterOverallSurvival,48.txt
properFunctioningOfSkeletalSystem,95.txt
highlightImportantConsiderations,75.txt
breastSurveillance,98.txt
promising,50.txt
age,103.txt
clinicalFeasibilityOfCtcIsolation,178.txt
moreLikely,129.txt
threeOverallSurvival,190.txt
period,57.txt
clinicalVisits,80.txt
age,110.txt
positiveHer2Expression,159.txt
found,135.txt
specificCircumstances,21.txt
advantageOfHigh-throughputLuminexTechnique,44.txt
tumors,199.txt
0.00001,13.txt
secondDecadeAfterDiagnosis,22.txt
required,169.txt
lessLikely,129.txt
typicalFeaturesIncludingFibrocysticBreastDisease,85.txt
highFreshLeafEthanolicExtractConcentrations,173.txt
inexpensive,52.txt
resistant,206.txt
finiteSamplePerformanceOfProposedMethods,63.txt
thromboembolicEvents,219.txt
Cell,106.txt
pcrResults,185.txt
additionalAnti-her2Therapy,139.txt
case,78.txt
ways,186.txt
quality,53.txt
significant,219.txt
planning,143.txt
pregnancy,231.txt
observedInTransfectionGroup,162.txt
variables,109.txt
carcinogenesis,174.txt
adherence,22.txt
inflammatoryCarcinoma,90.txt
pathologicallyTumor-freeNodes,143.txt
establishedOncogene,106.txt
examinations,50.txt
them,160.txt
significantlyProlongedMedianPfs,169.txt
study,46.txt
relativesOfPatientsWithPa,202.txt
complexDueToPotentialFoetalRisksInSettingOfMaternalTreatment,180.txt
group,163.txt
detection,235.txt
patientsByTrastuzumab-pretreatment,4.txt
outcome,151.txt
activationOfOther,77.txt
mostFrequentlyObserved,171.txt
tested,181.txt
findingsFromStudies,2.txt
europeanCountries,79.txt
detected,199.txt
exponentialTiltingSemiparametricModelAccountForNonignorableMissingDataMechanism,63.txt
frequency,104.txt
generalRadiologistAboutSystemicDiseases,30.txt
medianTimeToCnsRelapseOf31Years,93.txt
expressed,48.txt
effects,7.txt
public,79.txt
utility,16.txt
treatment,94.txt
asymptoticPropertiesOfEstimatesCalculatedFrom,63.txt
data,188.txt
significantEnrichmentOfCdh1MutationsWithinEcDomainsInComparisonToCdh1MutationsAssociatedWithHdgc,89.txt
lowIncomeCountries,53.txt
receiverOperatingCharacteristic,86.txt
clinicalTrials,201.txt
heterogeneousExpressionOfHumanEpidermalGrowthFactorReceptor2OnIndividualCancerCellSurface,239.txt
estimated,212.txt
cancerProgression,77.txt
needed,132.txt
upregulated,137.txt
synthesized,205.txt
radiomicsScore,194.txt
copyright,161.txt
signatures,190.txt
fibroadenoma,194.txt
10Countries,200.txt
kind,14.txt
rates,11.txt
variablesPredictiveOfNippleAreolaComplexInvolvementInPatients,109.txt
problem,206.txt
substantialSubsetOfTotalSample,183.txt
3Malignancies,191.txt
mitosisDyingByMitoticCatastrophe,198.txt
elusive,127.txt
youngerAgeGroup,161.txt
mrnaExpressionLevelOfPcdh10,185.txt
date,241.txt
incidenceFactorsOfSubsequentLung/bronchusPrimaries,118.txt
surveillanceData,103.txt
described,224.txt
cancerDeathAmongWomenWorldwide,101.txt
unclear,182.txt
largelyUnknown,23.txt
higher,44.txt
mean,19.txt
validatedAlgorithms,160.txt
ageOfTreatmentMethods,177.txt
trials,217.txt
breastCancer,172.txt
exosomesOf5-fu-resistantCrcCellsInThoseOfHighMetastaticCrcCells,206.txt
largestCancerPatientCohortStudies,112.txt
11BreastRadiologists,224.txt
unnecessaryRepeatBiopsies,226.txt
automatedAnalysisOfClinicallyRelevantHistopathologicFeature,37.txt
pre-operativeAssessment,147.txt
mostCommonCancer,225.txt
collected,163.txt
followedFromDateOfFirstDiagnosisOfAdToEndOf2013,66.txt
cases,44.txt
alarm,231.txt
overallCumulativeRiskOfProgression,93.txt
impact,87.txt
inPresentStudyConductedBetweenMcf-7Tamoxifen-resistantLcc2CellLines,70.txt
46NsclcPatientsBeforeChemotherapy,48.txt
breastCancer,97.txt
growth,215.txt
localExcision/lumpectomy,147.txt
information,30.txt
us,7.txt
drugResistance,206.txt
neoadjuvantChemotherapy,102.txt
efficientSignaturesForClinicalDiagnosis,190.txt
WHI,21.txt
patients'MedicalRecords,32.txt
severeThreat,159.txt
enhancementOfImage,144.txt
napsinAIn7Percecnt,12.txt
effects,140.txt
familyOfNoncodingRnas,137.txt
used,217.txt
mammography,148.txt
effect,93.txt
advancedDiagnosticImaging,134.txt
associated,140.txt
diffuseGastricCancerPresentedWithClp,89.txt
development,95.txt
typicalImagingPattern,104.txt
pertinent,84.txt
20PercecntIncreasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers,208.txt
expressed,44.txt
obtainedFromPatientsWithBreastCancer,150.txt
assessed,82.txt
role,74.txt
copyright,105.txt
venaCavaSyndrome,65.txt
factor,86.txt
optimalTherapeuticTargetForPatientWithAdvancedBreastCancer,197.txt
widelyUsed,60.txt
warranted,179.txt
quantified,104.txt
BMI,146.txt
differencesInAssayPerformance,74.txt
mustAddressedDuringCancerGeneticCounselingConsultations,138.txt
abbreviatedMriProtocols,207.txt
indispensable,189.txt
hasReduced,50.txt
meanwhileBetterThanInCapecitabineGroup,196.txt
patientsWithProlactinoma,202.txt
predicted,89.txt
malignantProgressionOfBreastCancer,229.txt
attenuatedCellGrowth,221.txt
approaches,151.txt
increasedDifferentiation,172.txt
trialsOfHer2-targetedTherapiesIn,201.txt
mostRelevantKind,14.txt
represented,59.txt
unclear,221.txt
fundamentalComponents,84.txt
trastuzumab,27.txt
outcomesOfEstrogenReceptorPositive,218.txt
inAdditionMeasured,244.txt
two-thirdsOfBreastCancerCases,70.txt
henceMainlyBased,193.txt
melanoma,115.txt
hasProposed,49.txt
alsoSignificantlyLower,162.txt
observed,236.txt
important,221.txt
upregulationOfE-cadherinExpressionLevels,130.txt
large,231.txt
effectsOfAnnexinA3OnBreastCancerBiologicalBehaviorInVivo,162.txt
Anemia,213.txt
linked,246.txt
designed,15.txt
moreCommonlyDiagnosed,202.txt
increasingCellCycleGeneExpression,106.txt
limitations,62.txt
classificationOfMammograms,49.txt
roleForPre-existingInborn-likeErrorsOfMetabolism,240.txt
patientsWithSmall-cellLungCancer,119.txt
due,166.txt
remodeled,77.txt
increase,182.txt
CRD42016048917,75.txt
computedTomographyOfBrain,166.txt
risk,208.txt
importantRoles,84.txt
correctionMethod,116.txt
implemented,207.txt
breastCancerStaging,52.txt
breastCancer,213.txt
significant,147.txt
signalTransductionMoleculesIncludingProteinKinaseC,46.txt
hasReducedThroughoutLastDecades,50.txt
humanErrors,144.txt
increasedRiskOfLong-termIncidentcvd,179.txt
protectiveEffectOfAspirinForCardiovascularEventsDuringItsConcomitantUseWithSelectiveEstrogenReceptorModulatorsInPreventionOfBreastCancer,219.txt
0.007,169.txt
developed,34.txt
retrospective,39.txt
kernelApproach,59.txt
adipocytes,95.txt
patientsFrom10Countries,200.txt
detected,197.txt
differentiallyExpressedCircularRnasInNeurologicalDisorders,137.txt
ultrasound,33.txt
popular,26.txt
182Percecnt,147.txt
influences,1.txt
differentPhotosensitizerForPhotodynamicTherapy,14.txt
canUsed,163.txt
couldDetectedEarly,5.txt
contrast,243.txt
greatPotentialOfClinicalApplication,178.txt
seValues,16.txt
only35CasesOfTraumaticBreastNeuromas,220.txt
inAdditionFurtherConfirmedInEarlyStage,238.txt
function,61.txt
relationshipBetweenNlr,238.txt
everolimusSideEffects,104.txt
multipleMitochondrialMetabolicPathways,153.txt
consequentlyHaveDeveloped,241.txt
standardAxillarySurgery,124.txt
Development,105.txt
presented,117.txt
tumourSpread,152.txt
neurocognitiveSequelae,76.txt
determinationOfUnderlyingBiologyWithinTumors,167.txt
betterOutcomeWithGoodNegativePredictiveValue,142.txt
organotropic,152.txt
comparingWithCurrentStandardMethodOfSubjectiveVisualEstimation,15.txt
study,112.txt
cancerSurvivors,2.txt
6084Years,1.txt
clinicians,158.txt
significantlyReduced,18.txt
dopamineAgonists,57.txt
used,35.txt
useful,232.txt
associationsWithDiseasesLikeTypeI,68.txt
invasion,130.txt
case,85.txt
lessLikely,66.txt
criticalRole,233.txt
breastCancer,86.txt
alternativeToFrozenSections,52.txt
treated,82.txt
incidenceOfCancer,112.txt
cases,215.txt
histopathologicalExamination,109.txt
developmentOfPolicies,157.txt
currentlyInsufficient,190.txt
shouldIdeallyAdministeredAtLeast1WeekBeforeCommencementOfAlkylatingTreatment,25.txt
commonEndocrineDisorder,117.txt
benignBreastLesions,150.txt
unknown,23.txt
CA-VTE,160.txt
moreoverAssociated,77.txt
potentialMechanism,105.txt
majorConcerns,139.txt
patients,238.txt
pcdh10GenePromoterMethylationIdentifiedInDuctalCarcinoma,185.txt
preservationOfBiomarkerExpressionInOldFfpeTumour,245.txt
haveDeveloped,241.txt
minimalRedundancyMaximalRelevanceAlgorithmAsFeatureSelectionMethods,170.txt
binding,134.txt
markersOfMesothelioma,51.txt
evidenceForEfficacyOfGonadotropin-releasingHormoneAgonists,25.txt
thematicAnalysis,138.txt
hazardsOfBleeding,160.txt
overLastYearsHaveProposedAsBiomarkersForCancerDetection,226.txt
treatmentOfEuropeanPatients,94.txt
found,117.txt
defined,66.txt
positive,147.txt
key,172.txt
firstDataOnPre-diagnosisConcentrationsOfSrankl,56.txt
tnmStage,178.txt
treated,196.txt
itsDifficultEarlyDiagnosis,159.txt
shouldOvercomeBeforeClinicalApplication,194.txt
willUsed,80.txt
persistentPain,217.txt
challengingProblem,59.txt
study,244.txt
metastasectomy,6.txt
diagnostics,12.txt
furthermoreRestricted,106.txt
boneLoss,26.txt
chemotherapy-inducedNeuropathy,46.txt
applicationsOfRadiomics,62.txt
needed,110.txt
713PercecntWithHighHeterogeneity,200.txt
needForAwarenessOfMimicsOfBoneMetastasis,38.txt
patients,32.txt
CMIA,16.txt
long-term,57.txt
right4,78.txt
highlyDiverseGroupOfMalignantNeoplasiaWithPoorOutcome,128.txt
theirInteractionsLikeGene-gene,68.txt
associatedWithBreastCancerRisk,56.txt
incidenceAmongMalignancies,127.txt
ageOf25Years,202.txt
neonatal,180.txt
needed,57.txt
identifiablePcrResults,185.txt
evidence,77.txt
nomogram,1.txt
biomarkers,206.txt
DOACs,160.txt
moreoverSignificantlyLower,162.txt
skinOriginatingFromInternalCancer,215.txt
uncommon,193.txt
consequentlyPredicted,89.txt
willUsedAsReferences,80.txt
nationalTrials,217.txt
lessBleedingThanTraditionalVenousThromboembolismInGeneralPopulation,160.txt
3GroupsBasedOnTertiarySolubleSt-2Level,163.txt
markerBands,234.txt
discovered,166.txt
applied,103.txt
detection,239.txt
potato,244.txt
dryness,151.txt
willLeadToMortalityReductionsWithoutUsualScreeningHarms,33.txt
505Percecnt,1.txt
classic,166.txt
performed,34.txt
multiplexPlatform,239.txt
accomplished,144.txt
grafts,8.txt
secretionOfTumorNecrosisFactor,82.txt
themselves,137.txt
twoGroups,184.txt
patients,232.txt
firstPatientsWithPathologicallyTumor-freeNodes,143.txt
hematoxylin,83.txt
denseBreasts,101.txt
particularlyPertinent,84.txt
highlyProblematicDose-limitingEffect,46.txt
delaysinTreatment,145.txt
canIncludedInDifferentialDiagnosisOfMasses,30.txt
life,186.txt
medianAgeOf50,200.txt
5-Fluorouraci,206.txt
proxyForcvd,179.txt
used,176.txt
managed,215.txt
prospectiveInformationAboutCharacteristicsOfWomenWithLungCancer,119.txt
bt549Cells,105.txt
reducedBaselineCardiacFunction,27.txt
accuracy,60.txt
analyzed,72.txt
dataOfN=,177.txt
used,185.txt
lungCancerInHuman,144.txt
1,19.txt
breastCancerScreeningProgramme,33.txt
breastCancerCells,131.txt
spectrum,152.txt
OSs,86.txt
trends,115.txt
termsOfKyotoEncyclopediaOfGenes,20.txt
role,106.txt
applied,170.txt
revealed,131.txt
brca1Wild-typeTripleNegativeBreastCancer,135.txt
interventionArm,33.txt
diagnosis,39.txt
inclined,238.txt
thenAdded,176.txt
ssessedByWoundHealingAssayinAddition,41.txt
heterogeneousDisease,20.txt
13-hDailyOvernightFast,151.txt
SCs,156.txt
rarelyMayDetected,104.txt
poorAdhesion,6.txt
performed,162.txt
signalAmplificationStrategies,176.txt
byDevelopmentOfHybridomaTechnologyHaveProducedInManyLaboratories,154.txt
variableMolecularMechanismsOfCarcinogenesis,218.txt
critical,189.txt
year,114.txt
practicePatterns,126.txt
inverselyCorrelated,131.txt
cancer,164.txt
treatmentOfBreastCancer,69.txt
disease,175.txt
significantIncrease,26.txt
couldSutegorizedIntoT2aWithCutoffValueOf3Cm,86.txt
regulationOfEmtProgressionOfSnaiFamilyMembers,130.txt
autonomyOfPatients,228.txt
differentPhenotypes,128.txt
whenIntegratedWithinCountry/region'sHealthPlan,157.txt
increasedCellApoptosis,221.txt
stratifyingForAge,188.txt
microadenomasDataOnLong-termRemissionRate,57.txt
healthCareSector,40.txt
prognosticSignificanceOfNeutrophil-to-lymphocyteRatioInPatientsWithBreastCancer,238.txt
amongYoungerPeopleCommon,161.txt
highestPerformance,175.txt
couldDeveloped,244.txt
sinceItsFirstDescriptionAtInstituteOfPathologyInKielAgoHasShown,74.txt
expressed,206.txt
tumorSite,23.txt
differences,23.txt
associated,65.txt
detected,41.txt
higher,202.txt
CTCs,169.txt
supportVectorMachine,20.txt
standardMethod,245.txt
malignancy,231.txt
softTissueSarcomas,72.txt
functions,190.txt
breastCancerGenes,110.txt
disposition,174.txt
effects,151.txt
breastCancerCells,81.txt
expressed,132.txt
significantlyCorrelated,246.txt
data,56.txt
used,226.txt
proliferation,209.txt
caseOf75-year-oldPatientWithDuctalInfiltratedCarcinoma,90.txt
theirOriginallyTargetedPopulationsOfBreastCancer,218.txt
measured,104.txt
expected,94.txt
responseFollowingAdministrationOfNeoadjuvantChemotherapy,240.txt
0.011,119.txt
required,189.txt
MCC,192.txt
physicalActivityInPatientsWithMetastaticBreastCancer,242.txt
women,230.txt
inPresentWorkHasProposedForBreastCancerDiagnosis,49.txt
challenge,211.txt
found,175.txt
avoidance,151.txt
hasWidelyUsed,101.txt
loss,33.txt
women,225.txt
healthcareUtilization,64.txt
risk,93.txt
her2/hrTripleNegativeTnmStages,118.txt
groupProfilesForSubgroup,183.txt
difference,192.txt
differentLevelsOfCk19,206.txt
variousImportantFunctions,18.txt
misdiagnosis,144.txt
postmenopausalWomenWithDevelopmentOfBreastCancer,146.txt
inCanadaOfferedInOrganizedPrograms,91.txt
explored,206.txt
90Percecnt,147.txt
51Days,147.txt
observed,162.txt
99PercecntOfCases,12.txt
lowDiagnosticSensitivityForWomenWithDenseBreasts,210.txt
roles,211.txt
classified,114.txt
diagnosis,134.txt
percent,213.txt
DDE,174.txt
case,90.txt
involved,77.txt
study,147.txt
selectiveEstrogenReceptorModulators,219.txt
block,198.txt
significantAssociationBetweenRs5743810AllelicFrequency,13.txt
haveSuggested,226.txt
generalHealth,151.txt
powerfulToolForEarlyDetection,240.txt
important,223.txt
collisionTumorWithBreastCancerMetastasis,10.txt
regression,194.txt
cause,213.txt
diseaseDefinedByTumor,167.txt
riskOfBreastRelapse,93.txt
2-3Years,100.txt
195Years,152.txt
associated,106.txt
interestingClassOfCompoundsWithVariedDegreesOfStructuralComplexity,181.txt
reverseTranscriptionQuantitativePolymeraseChainReaction,61.txt
patientsWithBreastCancer,163.txt
problemOfDiscriminationOfExosomes,206.txt
humanLife,28.txt
cavernousMalformation,73.txt
need,38.txt
needed,37.txt
assessed,109.txt
descriptive-analyticCross-sectionalType160FemalePatientsWasselected,47.txt
implemented,36.txt
Cells,77.txt
missed,220.txt
blackWomen,187.txt
article,166.txt
correlation,245.txt
consistent,236.txt
5T-mds/mpn,191.txt
issuesOfExistingContrastAgents,210.txt
breastCancerClassification,40.txt
womenOfReproductiveAge,117.txt
inPreprocessingHasAchieved,49.txt
developed,218.txt
required,75.txt
age,200.txt
important,70.txt
adherenceToRecommendationWith95PercecntConfidenceIntervals,129.txt
positiveChangesInTheirHealthBehaviours,129.txt
polymorphismOfFok1,95.txt
patients,1.txt
used,103.txt
discussed,220.txt
mostImportantCause,191.txt
periodFromApril2012ToDecember2017,23.txt
studies,75.txt
diindolylmethane,151.txt
breastCancer,103.txt
needForAnalysisOfMetastaticTissuesAtRecurrence,241.txt
associationOfToll-likeReceptor6WithBreastCancerInSaudiArabianWomen,13.txt
clinicalPractice,14.txt
operablePatients,120.txt
roles,84.txt
diseaseDiagnosis,68.txt
expression,120.txt
pathogenesisOfBreastCancer,3.txt
needsOfInformationSeekers,23.txt
painlessLumpInBreastAccountingFor688PercecntOfPatients,32.txt
riskOfDevelopmentOfGliomas,243.txt
long-termEstimates,7.txt
leadingCauseOfMorbidityWorldwideYetMethodsForEarlyDetection,240.txt
contexts,177.txt
cancer,111.txt
trastuzumabInitiation,27.txt
issues,210.txt
feasible,220.txt
aggressive,171.txt
haveReportedForFirstTimeInCaninesInStudy,44.txt
need,241.txt
role,58.txt
acuteDangerToMother,231.txt
intervalBetweenDiagnosis,108.txt
secondSurgery,6.txt
balfOfNsclcPatients,48.txt
real-worldSetting,4.txt
us,21.txt
growingProblem,72.txt
thusInRecentYearsDemand,114.txt
ourExperienceOfHigh-doseRadiotherapy,222.txt
fanconiAnemia,213.txt
6Years,191.txt
activityOfTransplantedTumors,162.txt
patientsWithHistoryOfBreastSurgery,220.txt
accuracy,20.txt
women,201.txt
betterUnderstandingOfRisksAssociatedWithM,32.txt
likelyParaneoplastic,67.txt
used,116.txt
formationOfCircularizedRna,137.txt
identified,118.txt
them,83.txt
poor,7.txt
activity,181.txt
old,107.txt
withandControllingForTreatmentDelays,145.txt
common,156.txt
severe,159.txt
481Women,187.txt
proposed,29.txt
analysed,183.txt
q12X,128.txt
biomarkers,174.txt
furthermoreAssociated,13.txt
changesToIntimateIssuesIncludingSexualHealth,230.txt
proposed,36.txt
particular,202.txt
nudeMouseModel,162.txt
alongsideRoutineMethodEmployedOnTexture,184.txt
haveDeveloped,201.txt
breastCancerYoungerThan45Years,214.txt
potential,210.txt
higherRatesOfMisdiagnosisForBreastCancer,11.txt
fieldOfCancerClassification,170.txt
postmenopausalPeriodWithDopamineAgonists,57.txt
analysis,41.txt
Cells,244.txt
howeverStillUnclear,221.txt
debated,79.txt
demonstrate,7.txt
ICER,33.txt
risks,98.txt
summarised,186.txt
amongOlderAdultsObservedForBreastCancerInFemalesForProstateCancerInMales,161.txt
oncogenicFunctionalityOfSpc24InBreastCancerProgression,221.txt
complication,164.txt
useOfAdvancedImagingExaminations,207.txt
doublingTimeOfOccult,21.txt
progressionOfTumorInvasionInBreastCarcinoma,246.txt
proteinLossOfPtenByPhosphorylation,171.txt
SE,16.txt
possibility,95.txt
mayNecessary,111.txt
suppressionOfBreastCancer,71.txt
analyzed,61.txt
indicated,95.txt
contralateralBreast,93.txt
uterine,115.txt
site-specificBindingLeadingToImprovedCancerTreatmentWithMinimalRisksToNormalCells,9.txt
screening,142.txt
5-khzFrequencies,19.txt
malignantPleuralEffusion,17.txt
scrutinized,108.txt
65Ng/mlForProgranulinFor-1,48.txt
breastCancerTherapy,151.txt
forThoseWithNormalLvef93Percecnt,27.txt
women,144.txt
appropriateAllocationOfResearchFunding,92.txt
detection,240.txt
occurrenceOfBreastCarcinoma,58.txt
isolatingExosomes,206.txt
strongIndependentPrognosticFactor,218.txt
suchLowIncidence,33.txt
earlyDiagnosis,175.txt
breastCancerPatientsWithParticularReferenceToOverallSurvivalAndrecurrenceFreeSurvivalAmongBreastCancerPatients,147.txt
similar,217.txt
findings,56.txt
selected,86.txt
featureMining,49.txt
stable,192.txt
veryRareCases,215.txt
required,220.txt
seen,109.txt
alarmingLevelGlobally,42.txt
theirEffectsOnHumanBreastCancerMda-mb-231CellGrowthInhibition,173.txt
effect,95.txt
greaterthanorequaltoReduction,27.txt
inductionOfFamily,140.txt
womenWithMore70PercecntOfPatientsTreatedWithHormonalTherapy,228.txt
unnecessaryFollow-upVisitsForWomenWithVeryLowRisks,188.txt
evenLessFrequentComplication,121.txt
insights,84.txt
decision-making,201.txt
complementaryApproaches,151.txt
after6Months'TherapySignificantlyHigherIn3rdTertiaryGroup,163.txt
suvmax39,104.txt
havePublished,72.txt
used,206.txt
heterogeneous,20.txt
505PercecntOfAnalyzedCases,1.txt
firstYearsAfterWithdrawal,57.txt
secondLeadingCause,101.txt
high-resolutionImages,134.txt
paclitaxel,46.txt
performed,164.txt
tumors,153.txt
show,114.txt
surgicalExcisionWithRadiation,37.txt
descriptiveStudy,35.txt
improvedDiagnosticContentOverEx-vivoClinicalMammographyImagesAtLowerDose,50.txt
upperGastrointestinalCancers,160.txt
related,112.txt
twoCases,73.txt
pathways,51.txt
PCI,76.txt
activity,242.txt
femaleBreastCancerMortality,54.txt
actSynergisticallyWithPaclitaxel,46.txt
atEndOfFollow-upClassifiedRegardingTheirAdherenceToRecommendationsForCancerPrevention,129.txt
oneRegionAnother,79.txt
rare,232.txt
breastCancer,240.txt
643Percecnt,187.txt
evidence,156.txt
add-onToConventionalUltrasoundEquipmentApplicable,36.txt
stillSeriousHealthProblemIn21stCenturySubjectToManyResearch,233.txt
tumor,219.txt
healthInitiative,21.txt
cosmesis,122.txt
life-threatening,65.txt
model2,2.txt
unitedStates,183.txt
youngerAge,243.txt
subsequentlyAssessed,224.txt
retrospectiveStudies,193.txt
overnight,151.txt
reproducingKernelHilbertSpace,59.txt
observed,171.txt
aberrations,171.txt
correspondingCohort,218.txt
circumferentialNarrowingOfCaecum,215.txt
resistant,127.txt
associated,160.txt
autopsyStudies,21.txt
CS,85.txt
axillary,124.txt
analysed,20.txt
incorrectDiagnosis,12.txt
cutoffValues,19.txt
SpCM,107.txt
antibody-basedStrategy,154.txt
known,11.txt
researchers,114.txt
disrupted,173.txt
itsWidespreadImplementation,148.txt
haveBackboneOfSuchEnormousStridesOfAu,9.txt
inhibited,221.txt
approved,217.txt
determinantGenes,170.txt
2IndependentCohorts,238.txt
allCloselyAssociatedWithPttTherapeuticEfficacy,159.txt
sensitive,144.txt
increasingNumber,193.txt
disease,131.txt
shouldStaged,167.txt
inLongTermHasFound,208.txt
based,24.txt
effect,82.txt
bilateralTotalMastectomies,67.txt
boneTumors,72.txt
expressionOfChemokineReceptor-4,105.txt
obtained,69.txt
applicationOfPhase-sensitiveTechniques,50.txt
spanishWomenWithLungCancer,119.txt
TTF-1,12.txt
features,152.txt
potentialTherapeuticTarget,154.txt
fourSelectedPopulation-basedCancerRegistries,161.txt
activity,244.txt
mouseModel,162.txt
masses,43.txt
uptakeOfTrastuzumab,200.txt
earlierAges,98.txt
younger,152.txt
determinantGenesRelatedToBreastCancerFromInitialGeneExpressionData,170.txt
made,71.txt
comparable,34.txt
patients'MedicalRecordsFromOctober2007ToDecember2012,119.txt
standardizedDataCollection,167.txt
cancer,49.txt
assessmentOfImpactOfAdvancesInDiagnosisOfPatientsWithBreastCancer,167.txt
explored,33.txt
widelyAcceptedAsStandardOfCareFollowingBreastConservation,143.txt
associated,70.txt
humanBreastCancerCells,156.txt
near-infraredLight-controllable,159.txt
medicalHistory,6.txt
decades,136.txt
numberOfSegmentInvolved,104.txt
importantForDiagnosis,175.txt
thatOfMir-511,131.txt
recursiveFeatureElimination,170.txt
information,119.txt
cruciferousVegetables,151.txt
presentedWorkForFeatureExtraction,114.txt
higherDetectionRatesOfArchitecturalDistortionParticularlyInPatientsWithDenseBreastTissue,155.txt
women,159.txt
ductalCarcinoma,1.txt
data,182.txt